Clinical Trials

Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

Condition:   Bacterial Conjunctivitis
Interventions:   Drug: azithromycin eye drops by essex;   Drug: azithromycin eye drops
Sponsors:   Beijing Tongren Hospital;   Zhuhai Essex Bio-Pharmaceutical Company Limited;   Panacea Technologies
Unknown status

Tue, 01 Aug 2017 12:00:00 EDT

An Open Label Trial of Azithromycin in Chronic Productive Cough

Condition:   Chronic Cough
Intervention:   Drug: Azithromycin
Sponsor:   University of Nottingham
Unknown status

Tue, 22 Jul 2014 12:00:00 EDT

Study to Determine the Effect of Azasite on Corneal Surface Irregularity

Condition:   Meibomian Gland Dysfunction
Intervention:   Drug: Azasite
Sponsors:   Philadelphia Eye Associates;   Merck Sharp & Dohme Corp.;   Thomas Jefferson University
Withdrawn

Fri, 22 Feb 2013 12:00:00 EST

Efficacy of Azithromycin in Treatment of Bronchiectasis

Condition:   Bronchiectasis
Interventions:   Drug: Azithromycin;   Drug: Placebo for Azithromycin
Sponsor:   Penang Hospital, Malaysia
Completed

Tue, 08 Apr 2014 12:00:00 EDT

Azithromycin Treatment for the Airway Microbiome in Asthma

Condition:   Asthma Chronic
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of Chicago;   Northwestern University
Unknown status

Fri, 09 Nov 2018 12:00:00 EST

Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

Condition:   Blepharitis
Intervention:   Drug: AzaSite®
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 06 Mar 2008 12:00:00 EST

Effect of Azithromycin on Fatty Acids in CF

Condition:   Cystic Fibrosis
Intervention:   Drug: Azithromycin
Sponsors:   University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn);   University of Bonn;   University Hospital, Frankfurt
Unknown status

Tue, 07 Feb 2017 12:00:00 EST

Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children

Conditions:   Pneumonia;   Diarrhea;   Malaria;   Co-infection;   Death;   Malnutrition
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of Washington;   Kenya Medical Research Institute;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed

Fri, 10 Apr 2015 12:00:00 EDT

Gut and Azithromycin Mechanisms in Infants and Children II

Condition:   Malaria
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Centre de Recherche en Sante de Nouna, Burkina Faso
Active, not recruiting

Thu, 19 Mar 2020 12:00:00 EDT

Azithromycin in the Treatment of M. Avium Complex Lung Disease

Condition:   Mycobacterium Avium Complex Lung Disease
Intervention:   Drug: Azithromycin
Sponsors:   The University of Texas Health Science Center at Tyler;   Pfizer
Completed

Wed, 23 Jan 2008 12:00:00 EST

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Condition:   Bacterial Infections
Intervention:   Drug: Azithromycin SR
Sponsor:   Pfizer
Completed

Tue, 20 Oct 2009 12:00:00 EDT

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation

Condition:   Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation
Intervention:   Drug: Azithromycin Dihydrate
Sponsors:   KU Leuven;   Fund for Scientific Research, Flanders, Belgium
Completed

Fri, 23 Apr 2010 12:00:00 EDT

A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease

Conditions:   Sickle Cell Disease;   Acute Chest Syndrome
Intervention:   Drug: Azithromycin
Sponsor:   University of Mississippi Medical Center
Withdrawn

Tue, 15 Dec 2015 12:00:00 EST


Azithromycin for Child Survival in Niger: Delivery Trial

Conditions:   Mortality;   Child Health;   Implementation
Intervention:   Drug: Azithromycin for Oral Suspension
Sponsors:   University of California, San Francisco;   Bill and Melinda Gates Foundation;   Programme National de Santé Oculaire, Ministère de la Santé Publique du Niger
Recruiting

Mon, 01 Mar 2021 12:00:00 EST

Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)

Condition:   Uncomplicated Severe Acute Malnutrition
Interventions:   Drug: Azithromycin;   Drug: Amoxicillin
Sponsors:   University of California, San Francisco;   Centre de Recherche en Sante de Nouna, Burkina Faso;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed

Tue, 26 Jun 2018 12:00:00 EDT

Mortality Reduction After Oral Azithromycin: Mortality Study

Condition:   Childhood Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Bill and Melinda Gates Foundation;   Johns Hopkins University;   London School of Hygiene and Tropical Medicine
Completed

Wed, 29 Jan 2014 12:00:00 EST

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19

Condition:   Sars-CoV2
Intervention:   Drug: Hydroxychloroquine and Azithromycin
Sponsors:   Latin American Cooperative Oncology Group;   Oncoclínicas
Withdrawn

Mon, 05 Oct 2020 12:00:00 EDT

Mortality Reduction After Oral Azithromycin: Morbidity Study

Condition:   Childhood Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Bill and Melinda Gates Foundation;   Johns Hopkins University;   London School of Hygiene and Tropical Medicine
Completed

Wed, 29 Jan 2014 12:00:00 EST

Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

Condition:   Acute Otitis Media
Interventions:   Drug: 60 mg/kg azithromycin ER;   Drug: 30 mg/kg azithromycin IR
Sponsor:   Pfizer
Completed

Mon, 24 Nov 2008 12:00:00 EST

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19

Condition:   Covid19
Intervention:   Drug: Hydroxychloroquine with Azithromycin
Sponsors:   Coordinación de Investigación en Salud, Mexico;   Ultra Laboratorios SA. de CV.
Recruiting

Fri, 16 Jul 2021 12:00:00 EDT

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

Condition:   Respiratory Syncytial Virus, Bronchiolitis
Interventions:   Drug: Oral azithromycin;   Drug: Placebo
Sponsor:   Washington University School of Medicine
Active, not recruiting

Thu, 22 Sep 2016 12:00:00 EDT

Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

Conditions:   Chronic Obstructive Pulmonary Disease Severe;   Chronic Bronchitis
Interventions:   Drug: Roflumilast;   Drug: Azithromycin
Sponsors:   Johns Hopkins University;   Patient-Centered Outcomes Research Institute
Recruiting

Wed, 28 Aug 2019 12:00:00 EDT

Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea

Conditions:   Diarrhea;   Fever;   Vomiting;   Abdominal Pain
Interventions:   Drug: azithromycin;   Drug: Placebo
Sponsors:   University of Aarhus;   Aalborg University Hospital;   Slagelse Hospital
Completed

Fri, 10 Feb 2012 12:00:00 EST

Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy

Conditions:   Chronic Rhinosinusitis;   High-risk Patient
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Pfizer
Completed

Thu, 04 Dec 2014 12:00:00 EST

Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Condition:   Familial Adenomatous Polyposis
Intervention:   Drug: Azithromycin Tablets
Sponsors:   Tel-Aviv Sourasky Medical Center;   Tel Aviv University
Not yet recruiting

Wed, 01 Jul 2020 12:00:00 EDT

Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans

Conditions:   Graft vs Host Disease;   Bronchiolitis Obliterans
Intervention:   Drug: azithromycin + N-acetylcystein + inhaled corticosteroid
Sponsor:   Asan Medical Center
Terminated

Fri, 01 Apr 2011 12:00:00 EDT

Azithromycin Reduction to Reach Elimination of Trachoma

Condition:   Trachoma
Intervention:   Drug: Azithromycin
Sponsors:   University of California, San Francisco;   Programme National de Santé Oculaire (PNSO)
Recruiting

Wed, 04 Dec 2019 12:00:00 EST

Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire

Conditions:   Child Mortality;   Azithromycin
Intervention:   Drug: Azithromycin
Sponsors:   FHI 360;   National Program for the Fight Against Neglected Tropical Diseases, Côte d'Ivoire
Completed

Thu, 05 Nov 2020 12:00:00 EST

Mortality Reduction After Oral Azithromycin Contingency: Mortality Study

Condition:   Childhood Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   The Carter Center;   Bill and Melinda Gates Foundation
Completed

Thu, 09 Nov 2017 12:00:00 EST

Azithromycin for Child Survival in Niger: Mortality and Resistance Trial

Conditions:   Mortality;   Resistance Bacterial;   Child, Only
Interventions:   Drug: Azithromycin;   Other: Placebo
Sponsors:   University of California, San Francisco;   Bill and Melinda Gates Foundation;   Ministry of Health, Niger
Recruiting

Mon, 13 Jan 2020 12:00:00 EST

Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants

Condition:   Ureaplasma Infections
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of Maryland, Baltimore;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Mercy Medical Center;   Johns Hopkins University;   University of Virginia;   University of Alabama at Birmingham;   Christiana Care Health Services
Completed

Tue, 29 Jan 2013 12:00:00 EST

The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis

Condition:   Chlamydial Conjunctivitis
Intervention:   Drug: Azithromycin
Sponsor:   National Taiwan University Hospital
Completed

Tue, 10 Aug 2010 12:00:00 EDT

PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients

Conditions:   Pharyngitis;   Tonsillitis
Intervention:   Drug: Azithromycin
Sponsor:   Pfizer
Terminated

Fri, 09 Aug 2013 12:00:00 EDT

Azithromycin for Meibomian Gland Disease

Conditions:   Dry Eye;   Neuropathic Eye Pain;   Ocular Microbiome;   Depression, Anxiety
Interventions:   Drug: Azithromycin Oral Product;   Drug: Placebo Oral
Sponsor:   University of California, San Francisco
Recruiting

Thu, 16 May 2019 12:00:00 EDT

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Condition:   Healthy
Interventions:   Drug: Azithromycin;   Drug: Zithromax®
Sponsor:   Teva Pharmaceuticals USA
Completed

Tue, 27 Jan 2009 12:00:00 EST

Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection

Condition:   Covid19
Intervention:   Drug: Atovaquone/Azithromycin
Sponsor:   HonorHealth Research Institute
Recruiting

Thu, 09 Apr 2020 12:00:00 EDT

Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

Condition:   HIV Infection
Intervention:   Drug: Azithromycin
Sponsors:   Pfizer;   Altmarc Inc.
Completed

Mon, 25 Oct 2010 12:00:00 EDT

A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial

Condition:   Trachoma
Interventions:   Other: Surveillance and treatment with azithromycin of newcomer and traveler families;   Other: Usual care
Sponsors:   Johns Hopkins University;   National Eye Institute (NEI)
Completed

Mon, 14 Jan 2013 12:00:00 EST

Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial

Condition:   Preterm Premature Rupture of Membrane
Interventions:   Drug: Azithromycin 500 mg;   Drug: Azithromycin Oral Product
Sponsor:   Thomas Jefferson University
Recruiting

Tue, 03 Mar 2020 12:00:00 EST

Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis

Condition:   Blepharitis
Intervention:   Drug: AzaSite®
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Fri, 11 Apr 2008 12:00:00 EDT

The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough

Conditions:   Cough;   Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis
Interventions:   Drug: azithromycin;   Drug: placebo
Sponsor:   Isala
Completed

Fri, 19 Feb 2010 12:00:00 EST

Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation

Condition:   Disorder Related to Lung Transplantation
Interventions:   Drug: Azithromycin;   Drug: Ora-Plus
Sponsors:   Universitaire Ziekenhuizen Leuven;   Fund for Scientific Research, Flanders, Belgium;   KU Leuven
Completed

Fri, 02 Aug 2013 12:00:00 EDT

Trial Comparing the Effect of Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Neisseria Gonorrhoeae on the Resistome

Condition:   Neisseria Gonorrhoeae
Interventions:   Drug: Rocephin;   Drug: Azithromycin
Sponsor:   Institute of Tropical Medicine, Belgium
Not yet recruiting

Mon, 30 Aug 2021 12:00:00 EDT

Azithromycin in Control of Trachoma II

Condition:   Trachoma
Intervention:   Drug: Azithromycin
Sponsors:   University of California, San Francisco;   National Institute of Allergy and Infectious Diseases (NIAID)
Withdrawn

Thu, 02 Feb 2006 12:00:00 EST

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

Conditions:   Pneumonia;   Pelvic Inflammatory Disease
Intervention:   Drug: Azithromycin IV
Sponsor:   Pfizer
Completed

Thu, 23 Aug 2012 12:00:00 EDT

Absorption of Drugs Post-Bariatric Surgery (Absorb-Azithromycin)

Condition:   Bariatric Surgery
Intervention:   Drug: Azithromycin
Sponsor:   University of Alberta
Completed

Thu, 01 Jul 2010 12:00:00 EDT

Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis

Condition:   Tuberculosis, Pulmonary
Intervention:   Drug: Azithromycin 250 mg
Sponsor:   University Medical Center Groningen
Unknown status

Fri, 19 May 2017 12:00:00 EDT

Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

Condition:   Pharmacokinetics
Intervention:   Drug: azithromycin eyedrop
Sponsors:   Beijing Tongren Hospital;   Grand Pharmaceutical (China) Co., Ltd.
Unknown status

Thu, 17 Aug 2017 12:00:00 EDT

Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)

Condition:   Cystic Fibrosis
Interventions:   Drug: azithromycin;   Drug: placebo (for azithromycin);   Drug: inhaled tobramycin
Sponsors:   Seattle Children's Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   Cystic Fibrosis Foundation;   CF Therapeutics Development Network Coordinating Center
Completed

Tue, 09 Feb 2016 12:00:00 EST

Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery

Conditions:   Bacterial Infections;   Eye Infections;   Cataract Extraction
Interventions:   Drug: AzaSite Eye Drops;   Drug: Vigamox Eye Drops
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 18 Dec 2007 12:00:00 EST

Infant Mortality Reduction by the Mass Administration of Azithromycin

Condition:   Child Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Helen Keller International;   Centre de Recherche en Sante de Nouna, Burkina Faso;   Bill and Melinda Gates Foundation
Not yet recruiting

Wed, 20 Jan 2021 12:00:00 EST

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

Conditions:   Bacterial Infections;   Eye Infections
Interventions:   Drug: Azithromycin;   Drug: Moxifloxacin
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Wed, 28 Nov 2007 12:00:00 EST

A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)

Condition:   COVID-19
Intervention:   Drug: Azithromycin Capsule
Sponsors:   University of Oxford;   Pfizer
Completed

Mon, 11 May 2020 12:00:00 EDT

Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage

Condition:   Preterm Birth
Intervention:   Drug: Azithromycin Tablets
Sponsor:   Ain Shams Maternity Hospital
Completed

Thu, 20 Feb 2020 12:00:00 EST

Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

Condition:   Respiratory Syncytial Virus
Interventions:   Drug: Azithromycin 10 mg;   Drug: Azithromycin 20mg;   Drug: Placebo
Sponsor:   University of Alabama at Birmingham
Completed

Mon, 14 Mar 2016 12:00:00 EDT

AZithromycin Against pLacebo in Exacerbations of Asthma

Condition:   Asthma
Interventions:   Drug: Zithromax;   Drug: Placebo
Sponsors:   Imperial College London;   National Institute for Health Research, United Kingdom
Completed

Fri, 30 Sep 2011 12:00:00 EDT

Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years

Condition:   Cystic Fibrosis
Intervention:   Drug: Azithromycin
Sponsor:   Hospices Civils de Lyon
Completed

Fri, 17 Jun 2016 12:00:00 EDT

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

Condition:   Bacterial Conjunctivitis
Interventions:   Drug: AzaSite;   Other: Vehicle
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Wed, 16 Mar 2005 12:00:00 EST

Oral Azithromycin Versus Doxycycline in Posterior Blepharitis

Condition:   Posterior Blepharitis
Interventions:   Drug: Azithromycin;   Drug: Doxycycline
Sponsor:   Tehran University of Medical Sciences
Completed

Tue, 05 Feb 2013 12:00:00 EST

The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery

Condition:   Endometritis
Intervention:   Drug: Azithromycin
Sponsor:   University of Alabama at Birmingham
Completed

Fri, 04 Nov 2011 12:00:00 EDT

Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)

Conditions:   Malaria in Pregnancy;   Pregnancy
Interventions:   Drug: Sulfadoxine pyrimethamine;   Drug: Azithromycin
Sponsor:   Federal Medical Centre, Owo
Unknown status

Thu, 09 May 2019 12:00:00 EDT

REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire

Condition:   Child Mortality
Intervention:   Drug: Single-dose azithromycin
Sponsors:   FHI 360;   Programme National de Lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive, Côte d'Ivoire
Not yet recruiting

Mon, 23 Aug 2021 12:00:00 EDT

Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy

Condition:   Graves Ophthalmopathy
Intervention:   Drug: Azithromycin
Sponsor:   Rabin Medical Center
Withdrawn

Thu, 23 Jun 2011 12:00:00 EDT

Vitamin A and Azithromycin for Acne Vulgaris

Condition:   Acne Vulgaris
Interventions:   Drug: Vitamin A;   Drug: Azithromycin
Sponsor:   Manchanda Medical Clinic
Not yet recruiting

Fri, 24 Mar 2017 12:00:00 EDT

Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea

Condition:   Yaws
Intervention:   Drug: Azithromycin
Sponsors:   Lihir Medical Centre;   Barcelona Institute for Global Health;   National Department of Health of Papua New Guinea;   World Health Organization;   University of Washington
Completed

Mon, 07 Oct 2013 12:00:00 EDT

Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States

Condition:   Bioequivalence
Interventions:   Drug: Azithromycin Tablet manufactured in China;   Drug: Azithromycin Tablet manufactured in US
Sponsor:   Pfizer
Completed

Mon, 27 Nov 2017 12:00:00 EST

Efficacy of Azithromycin as an Adjunct to Non-Surgical Periodontal Treatment

Condition:   Periodontitis
Interventions:   Other: Lactose tab;   Drug: Azithromycin
Sponsor:   Universidad Nacional Andres Bello
Completed

Tue, 14 Aug 2018 12:00:00 EDT

A Study of Standard Drugs for Mycobacterium Avium Complex

Condition:   Mycobacterium Avium Complex
Intervention:   Drug: Azithromycin
Sponsor:   Johns Hopkins University
Recruiting

Thu, 27 Feb 2020 12:00:00 EST

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

Conditions:   Malaria;   Pregnant;   HIV
Interventions:   Drug: Sulphadoxine-pyrimethamine;   Drug: Azithromycin
Sponsor:   University of Ibadan
Completed

Tue, 18 Aug 2015 12:00:00 EDT

AZMATICS: AZithroMycin/Asthma Trial In Community Settings

Condition:   Asthma
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of Wisconsin, Madison;   American Academy of Family Physicians;   Dean Foundation;   Pfizer
Completed

Mon, 19 Dec 2005 12:00:00 EST

Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso

Condition:   Childhood Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Centre de Recherche en Sante de Nouna, Burkina Faso;   Bill and Melinda Gates Foundation
Active, not recruiting

Mon, 24 Sep 2018 12:00:00 EDT

Azithromycin in Bronchiolitis Obliterans Syndrome

Conditions:   Bronchiolitis Obliterans Syndrome;   Graft Rejection;   Lymphocytic Bronchiolitis;   Respiratory Infection
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   KU Leuven;   University Hospital, Gasthuisberg;   Fund for Scientific Research, Flanders, Belgium
Completed

Mon, 09 Nov 2009 12:00:00 EST

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

Condition:   Bacterial Conjunctivitis
Interventions:   Drug: AzaSite;   Drug: Tobramycin
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 15 Mar 2005 12:00:00 EST

Prevention of Bronchiectasis in Infants With Cystic Fibrosis

Conditions:   Cystic Fibrosis;   Bronchiectasis
Interventions:   Drug: Azithromycin;   Drug: Placebo control
Sponsors:   The University of Queensland;   Telethon Kids Institute
Completed

Wed, 05 Jan 2011 12:00:00 EST

Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia

Condition:   Mycoplasma Pneumoniae Pneumonia
Interventions:   Drug: Azithromycin plus Xiyanping injection;   Drug: Azithromycin
Sponsor:   Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Not yet recruiting

Thu, 05 Mar 2020 12:00:00 EST

Aizthromycin or Clarithromycin in H-pylori Eradication Regimen

Conditions:   Peptic Ulcer;   Dyspepsia;   H-pylori
Interventions:   Drug: azithromycin;   Drug: clarithmycin
Sponsor:   Shahid Sadoughi University of Medical Sciences and Health Services
Completed

Fri, 17 Aug 2012 12:00:00 EDT

Azithromycin in Idiopathic Pulmonary Fibrosis

Conditions:   Idiopathic Pulmonary Fibrosis;   Cough
Interventions:   Drug: azithromycin;   Drug: placebo
Sponsors:   University Hospital Inselspital, Berne;   University of Bern
Completed

Tue, 24 Jun 2014 12:00:00 EDT

Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome

Condition:   Haemolytic and Uremic Syndrome
Interventions:   Drug: Azithromycin;   Drug: Placebo (glucose solution 10%)
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed

Tue, 13 Jan 2015 12:00:00 EST

Anti-viral Effects of Azithromycin in Patients With Asthma and COPD

Conditions:   Asthma;   COPD;   Exacerbation Copd;   Asthma; Eosinophilic;   Bronchial Diseases;   Lung Diseases, Obstructive;   Lung Diseases;   Immune System Diseases
Interventions:   Drug: Azithromycin;   Drug: Placebo oral tablet
Sponsors:   Bispebjerg Hospital;   Lund University;   University of Copenhagen;   Herlev and Gentofte Hospital
Recruiting

Tue, 24 Mar 2020 12:00:00 EDT

Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa

Condition:   Cystic Fibrosis
Interventions:   Drug: azithromycin 250 mg tablets;   Drug: placebo tablets
Sponsors:   CF Therapeutics Development Network Coordinating Center;   Cystic Fibrosis Foundation
Completed

Tue, 06 Feb 2007 12:00:00 EST

Azithromycin a Treatment for Pulmonary Sarcoidosis

Condition:   Sarcoidosis, Pulmonary
Intervention:   Drug: Azithromycin 250Mg Capsule
Sponsor:   Hull University Teaching Hospitals NHS Trust
Completed

Tue, 16 Jul 2019 12:00:00 EDT

Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death

Condition:   Neonatal SEPSIS
Interventions:   Drug: Azithromycin;   Drug: Placebo Oral Tablet
Sponsor:   London School of Hygiene and Tropical Medicine
Completed

Tue, 27 Jun 2017 12:00:00 EDT

Improving Care Through Azithromycin Research for Infants in Africa

Condition:   Child Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Barcelona Institute for Global Health;   University of Sierra Leone;   Bill and Melinda Gates Foundation;   Ministry of Health and Sanitation, Sierra Leone
Recruiting

Wed, 22 Jan 2020 12:00:00 EST

Azithromycin for Acute Exacerbations Requiring Hospitalization

Condition:   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Wim Janssens;   Agentschap voor Innovatie door Wetenschap en Technologie
Terminated

Fri, 09 May 2014 12:00:00 EDT

Azithromycin for COVID-19 Treatment in Outpatients Nationwide

Conditions:   COVID-19;   SARS-CoV-2
Interventions:   Drug: Azithromycin;   Drug: Placebos
Sponsors:   Thomas M. Lietman;   Bill and Melinda Gates Foundation;   Pfizer;   Stanford University
Terminated

Thu, 02 Apr 2020 12:00:00 EDT

Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis

Condition:   Blepharitis
Intervention:   Drug: AzaSite®
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 06 Mar 2008 12:00:00 EST

Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsor:   University of New Mexico
Active, not recruiting

Tue, 07 Jul 2020 12:00:00 EDT

Azithromycin for Children Hospitalized With Asthma

Condition:   Asthma
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   Montefiore Medical Center
Terminated

Fri, 06 Dec 2013 12:00:00 EST

Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis

Condition:   Blepharitis
Intervention:   Drug: AzaSite®
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 06 Mar 2008 12:00:00 EST

Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa

Condition:   Asymptomatic Parasitemia In Pregnancy
Intervention:   Drug: Azithromycin plus chloroquine
Sponsor:   Pfizer
Terminated

Thu, 15 Apr 2010 12:00:00 EDT

The Effect of Azithromycin in the Treatment of Chronic Periodontitis

Condition:   Chronic Periodontitis
Interventions:   Drug: 1% Azithromycin gel;   Drug: Azithromycin;   Drug: placebo gel;   Drug: placebo capsule
Sponsor:   Isfahan University of Medical Sciences
Completed

Tue, 13 Aug 2013 12:00:00 EDT

YCFM (Youth Correctional Facilities Males)

Condition:   Chlamydial Infection
Intervention:   Drug: Azithromycin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Tue, 15 Aug 2017 12:00:00 EDT

Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease

Condition:   Mycobacterium Avium Complex
Interventions:   Drug: Azithromycin;   Drug: Rifabutin/rifampin
Sponsors:   The University of Texas Health Science Center at Tyler;   Pfizer
Completed

Wed, 23 Jan 2008 12:00:00 EST

Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

Conditions:   Postpartum Sepsis;   Postpartum Endometritis;   Postpartum Fever
Interventions:   Drug: Azithromycin;   Drug: Azithromycin and amoxicillin;   Drug: Placebo
Sponsors:   University of Alabama at Birmingham;   Merck Sharp & Dohme Corp.
Completed

Mon, 14 Aug 2017 12:00:00 EDT

Community Health Azithromycin Trial in Burkina Faso

Condition:   Childhood Mortality
Interventions:   Drug: Azithromycin;   Drug: Placebos
Sponsors:   University of California, San Francisco;   Centre de Recherche en Sante de Nouna, Burkina Faso;   Bill and Melinda Gates Foundation
Recruiting

Wed, 19 Sep 2018 12:00:00 EDT

Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali

Condition:   Mortality
Interventions:   Drug: Placebo;   Drug: Azithromycin
Sponsors:   Tampere University;   Center for Vaccine Development CVD-Mali, Bamako, Mali;   University College London Hospitals;   Tro Da Ltd, UK;   Duke-NUS Graduate Medical School;   Bill and Melinda Gates Foundation (Funder);   Pfizer Inc. (Provider of study drugs)
Recruiting

Thu, 11 Jun 2020 12:00:00 EDT

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis

Condition:   Malaria, Falciparum
Interventions:   Drug: Azithromycin capsules;   Drug: Placebo;   Biological: Immunization with falciparum
Sponsors:   Radboud University;   Leiden University Medical Center;   Medicines for Malaria Venture
Withdrawn

Mon, 04 Feb 2013 12:00:00 EST

The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)

Condition:   Typhoid Fever
Interventions:   Drug: Azithromycin;   Drug: Cefixime;   Drug: Placebo
Sponsors:   Oxford University Clinical Research Unit, Vietnam;   University of Oxford;   Medical Research Council;   Department for International Development, United Kingdom;   Wellcome Trust
Not yet recruiting

Thu, 16 Apr 2020 12:00:00 EDT

Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin

Condition:   Pityriasis Lichenoides
Interventions:   Drug: Azithromycin;   Other: nbUVB
Sponsor:   Cairo University
Unknown status

Tue, 05 Feb 2019 12:00:00 EST

Single Dose Azithromycin to Prevent Cholera in Children

Condition:   Cholera
Interventions:   Drug: Azithromycin;   Biological: Placebo
Sponsors:   Massachusetts General Hospital;   International Centre for Diarrhoeal Disease Research, Bangladesh
Not yet recruiting

Mon, 30 Mar 2020 12:00:00 EDT

Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)

Condition:   Urethritis
Interventions:   Drug: Azithromycin;   Drug: Doxycycline
Sponsors:   University of Washington;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Mon, 31 Jul 2006 12:00:00 EDT

Trial for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children

Condition:   Asthma
Interventions:   Drug: Azithromycin;   Drug: Suspension Placebo
Sponsors:   Janielee Williamson;   University of Alberta
Unknown status

Fri, 06 Nov 2009 12:00:00 EST

Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)

Conditions:   Legionnaires' Disease;   Legionella Pneumophila Infections
Intervention:   Drug: Azithromycin IV
Sponsor:   Pfizer
Completed

Wed, 06 Feb 2013 12:00:00 EST

Azithromycin in the Prevention of Lung Injury in Premature Newborn

Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   Hospital de Clinicas de Porto Alegre
Completed

Mon, 02 Apr 2018 12:00:00 EDT

Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis

Condition:   RSV Bronchiolitis
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   Washington University School of Medicine
Completed

Tue, 06 Dec 2011 12:00:00 EST

Metronidazole vs Azithromycin in Periodontal Surgery for Patients Positive to Porphyromonas Gingivalis

Conditions:   Periodontitis;   Surgery
Interventions:   Other: Azithromycin;   Other: Metronidazole
Sponsor:   Universidad Complutense de Madrid
Unknown status

Tue, 05 Mar 2019 12:00:00 EST

The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)

Condition:   Community Acquired Pneumonia (CAP)
Intervention:   Drug: Azithromycin
Sponsor:   Pfizer
Completed

Wed, 17 Dec 2008 12:00:00 EST

Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis

Condition:   Bronchiectasis
Intervention:   Drug: Azithromycin
Sponsors:   Instituto de Investigacion Sanitaria La Fe;   Sociedad Valenciana de Neumología
Completed

Tue, 01 Nov 2011 12:00:00 EDT

Drug Interaction Study of Azithromycin and Theophylline

Conditions:   Chronic Obstructive Pulmonary Disease;   Asthma
Interventions:   Drug: Theophylline with azithromycin;   Drug: Theophylline alone
Sponsor:   Zhujiang Hospital
Completed

Mon, 30 Dec 2013 12:00:00 EST

Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia

Conditions:   Pneumonia, Ventilator-Associated;   Pseudomonas Infections
Interventions:   Drug: azithromycin;   Drug: placebo
Sponsors:   Anbics Management-Services Ag;   Swiss National Science Foundation
Terminated

Fri, 08 Feb 2008 12:00:00 EST

Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children

Condition:   Sinusitis
Interventions:   Drug: placebo;   Drug: azithromycin
Sponsor:   Mahidol University
Completed

Thu, 23 Jul 2009 12:00:00 EDT

Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsors:   Intermountain Health Care, Inc.;   University of Utah
Active, not recruiting

Wed, 01 Apr 2020 12:00:00 EDT

Drug-Drug Interaction Study of Colchicine and Azithromycin

Condition:   Pharmacokinetics
Interventions:   Drug: Colchicine;   Drug: Azithromycin
Sponsor:   Mutual Pharmaceutical Company, Inc.
Completed

Thu, 24 Sep 2009 12:00:00 EDT

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

Condition:   Healthy
Interventions:   Other: Azithromycin;   Drug: Zithromax®
Sponsor:   Teva Pharmaceuticals USA
Completed

Tue, 27 Jan 2009 12:00:00 EST

Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsors:   Intermountain Health Care, Inc.;   University of Utah;   Utah Department of Health
Recruiting

Mon, 06 Apr 2020 12:00:00 EDT

Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis

Condition:   Maxillary Sinusitis
Interventions:   Drug: Azithromycin SR;   Drug: Amoxiclav 1000 mg
Sponsor:   Pfizer
Completed

Tue, 15 Dec 2009 12:00:00 EST

Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis

Condition:   Cutaneous Leishmaniasis
Interventions:   Drug: Glucantime®;   Drug: Zithromax ®
Sponsors:   Ana Rabello;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Terminated

Thu, 22 May 2008 12:00:00 EDT

Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Condition:   Pelvic Inflammatory Disease
Intervention:   Drug: Azithromycin
Sponsor:   Pfizer
Completed

Mon, 30 Mar 2009 12:00:00 EDT

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Conditions:   Coronavirus Infections;   Pneumonia, Viral
Interventions:   Drug: Hydroxychloroquine + azithromycin;   Drug: Hydroxychloroquine
Sponsors:   Hospital Israelita Albert Einstein;   EMS;   Hospital do Coracao;   Hospital Sirio-Libanes;   Brazilian Research In Intensive Care Network
Completed

Wed, 25 Mar 2020 12:00:00 EDT

Azithromycin 600 Mg Tablets, Fed

Condition:   Healthy
Interventions:   Drug: Azithromycin 600 mg Tablet;   Drug: Zithromax® 600 mg Tablet
Sponsor:   Teva Pharmaceuticals USA
Completed

Tue, 03 Feb 2009 12:00:00 EST

Azithromycin 600 Mg Tablets, Fasting

Condition:   Healthy
Interventions:   Drug: Azithromycin 600 mg Tablet;   Drug: Zithromax® 600 mg Tablet
Sponsor:   Teva Pharmaceuticals USA
Completed

Tue, 03 Feb 2009 12:00:00 EST

Single-dose Azithromycin for the Treatment of Yaws

Conditions:   Yaws;   Treponema Infection;   Neglected Tropical Disease
Interventions:   Drug: Penicillin-G-benzathine;   Drug: Azithromycin
Sponsors:   Lihir Medical Centre;   Centre For International Health
Completed

Mon, 27 Jun 2011 12:00:00 EDT

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Conditions:   Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions:   Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)
Sponsor:   Adapt Produtos Oftalmológicos Ltda.
Withdrawn

Tue, 06 Nov 2012 12:00:00 EST

A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women

Conditions:   Pregnancy;   Infections, Plasmodia;   Drug Kinetics;   Clinical Efficacy
Interventions:   Drug: Azithromycin plus piperaquine phosphate;   Drug: Sulfadoxine-pyrimethamine
Sponsors:   Papua New Guinea Institute of Medical Research;   The University of Western Australia;   University of Melbourne;   Malaria in Pregnancy Consortium
Unknown status

Thu, 15 Oct 2015 12:00:00 EDT

Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)

Conditions:   Coronavirus Infection;   Pneumonia, Viral
Interventions:   Drug: Hydroxychloroquine + placebo;   Drug: hydroxychloroquine + azithromycin
Sponsor:   University Hospital, Montpellier
Terminated

Wed, 15 Apr 2020 12:00:00 EDT

Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction

Conditions:   Dry Eye Syndromes;   Meibomian Gland Dysfunction
Interventions:   Drug: Azithromycin;   Drug: Doxycycline
Sponsor:   Medical University of Vienna
Recruiting

Mon, 22 May 2017 12:00:00 EDT

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Condition:   Covid-19
Interventions:   Drug: Hydroxychloroquine Sulfate;   Drug: Azithromycin Tablets
Sponsor:   Azidus Brasil
Suspended

Thu, 16 Apr 2020 12:00:00 EDT

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

Condition:   Blepharitis
Interventions:   Drug: ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined);   Drug: Azasite;   Drug: Dexamethasone;   Other: Vehicle
Sponsor:   Sun Pharma Global FZE
Completed

Wed, 03 Aug 2011 12:00:00 EDT

MORDOR II Burkina Faso: Longitudinal Trial

Conditions:   Child Growth;   Diversity of Microbiome;   Child Mortality;   Resistance Bacterial
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Centre de Recherche en Sante de Nouna, Burkina Faso;   Bill and Melinda Gates Foundation
Completed

Wed, 19 Sep 2018 12:00:00 EDT

Azithromycin for Preterm Pre-labor Rupture of Membranes

Condition:   Preterm Pre-labor Rupture of Membranes
Interventions:   Drug: Azithromycin;   Drug: Ampicillin
Sponsor:   Assiut University
Not yet recruiting

Tue, 17 Dec 2019 12:00:00 EST

Effect of Azithromycin on Failure Proportion of Severe Periodontitis Non-surgical Treatment

Condition:   Severe Chronic Periodontitis
Interventions:   Drug: Non-surgical periodontal treatment and azithromycin treatment;   Other: Non-surgical periodontal treatment and placebo treatment
Sponsor:   University Hospital, Strasbourg, France
Not yet recruiting

Fri, 13 Dec 2019 12:00:00 EST

Trachoma Elimination Study by Focused Antibiotic (TESFA)

Condition:   Trachoma
Interventions:   Drug: Azithromycin mass treatment;   Drug: Azithromycin targeted treatment
Sponsors:   Emory University;   The Carter Center
Suspended

Mon, 14 May 2018 12:00:00 EDT

Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

Condition:   Respiratory Tract Infection Viral
Intervention:   Drug: Azithromycin plus hydroxychloroquine
Sponsors:   Iterum Therapeutics, International Limited;   Waterbury Hospital
Withdrawn

Mon, 30 Aug 2021 12:00:00 EDT

Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections

Condition:   Respiratory Tract Infections
Intervention:   Drug: Azithromycin
Sponsor:   Pfizer
Completed

Tue, 14 Jul 2009 12:00:00 EDT

Cefixime / Azithromycin pK Study

Condition:   Gonorrhoea
Interventions:   Drug: Azithromycin;   Drug: Cefixime
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Tue, 15 Mar 2016 12:00:00 EDT

Prevention of Bacterial Infections in Newborn

Condition:   Neonatal Infection
Intervention:   Drug: Azithromycin and Placebo
Sponsor:   London School of Hygiene and Tropical Medicine
Completed

Thu, 28 Feb 2013 12:00:00 EST

Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea

Conditions:   Malaria in Pregnancy;   Sexually Transmitted Infections;   Anaemia
Interventions:   Drug: chloroquine, sulphadoxine pyrimethamine, LLIN;   Drug: azithromycin, sulphadoxine pyrimethamine, LLIN
Sponsors:   University of Melbourne;   Papua New Guinea Institute of Medical Research;   The University of Western Australia;   Walter and Eliza Hall Institute of Medical Research;   University of Barcelona
Completed

Fri, 04 Jun 2010 12:00:00 EDT

Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)

Conditions:   Crohn Disease;   Pediatric Crohns Disease
Interventions:   Drug: Azithromycin;   Drug: Metronidazole;   Other: Standard of Care
Sponsors:   University of North Carolina, Chapel Hill;   Crohn's and Colitis Foundation;   University of Amsterdam
Not yet recruiting

Wed, 04 Dec 2019 12:00:00 EST

Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: Azithromycin + Metronidazole;   Drug: Metronidazole
Sponsor:   Prof. Arie Levine
Completed

Fri, 11 May 2012 12:00:00 EDT

Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.

Condition:   Randomized Controll Trial
Intervention:   Drug: Azithromycin
Sponsor:   Ain Shams University
Unknown status

Wed, 18 Apr 2018 12:00:00 EDT

Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women

Condition:   Chlamydia Trachomatis Infection
Interventions:   Drug: Rifalazil 25 milligram;   Drug: Azithromycin 1 gram
Sponsor:   ActivBiotics Pharma, LLC
Completed

Fri, 29 Jun 2012 12:00:00 EDT

Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection

Condition:   Covid19
Interventions:   Drug: Clarithromycin 500mg;   Drug: Azithromycin;   Drug: Placebo
Sponsor:   South Valley University
Completed

Tue, 10 Nov 2020 12:00:00 EST

Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19

Conditions:   Acute Respiratory Distress Syndrome;   Covid19
Interventions:   Drug: Hydroxychloroquine Pill + Azithromycin Pill;   Drug: SOC
Sponsor:   Maimónides Biomedical Research Institute of Córdoba
Recruiting

Thu, 08 Jul 2021 12:00:00 EDT

Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial

Condition:   COVID19
Interventions:   Drug: Hydroxychloroquine and azithromycin treatment;   Other: conventional management of patients
Sponsor:   Hospital St. Joseph, Marseille, France
Withdrawn

Tue, 28 Apr 2020 12:00:00 EDT

A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications

Condition:   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Azithromycin;   Other: HP xenon (¹²⁹XE)
Sponsor:   Genentech, Inc.
Not yet recruiting

Mon, 20 Apr 2020 12:00:00 EDT

Efficacy of Adding Azithromycin to Cephalosporin Before Cesarean Delivery

Condition:   Wound Sepsis
Interventions:   Drug: cephalosporin;   Drug: Azithromycin Tablets
Sponsor:   Ain Shams University
Completed

Tue, 20 Aug 2019 12:00:00 EDT

Azithromycin in Hospitalized COVID-19 Patients

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsor:   Shahid Beheshti University of Medical Sciences
Not yet recruiting

Fri, 24 Apr 2020 12:00:00 EDT

Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery

Conditions:   Dysentery, Shigella;   Shigellosis;   Diarrhea
Interventions:   Drug: Ciprofloxacin;   Drug: Azithromycin
Sponsors:   Oxford University Clinical Research Unit, Vietnam;   Children's Hospital Number 2, Ho Chi Minh City, Vietnam;   University of Liverpool
Recruiting

Tue, 26 Feb 2019 12:00:00 EST

Trial II of Lung Protection With Azithromycin in the Preterm Infant

Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Hubert Ballard;   American Lung Association
Completed

Thu, 27 Apr 2006 12:00:00 EDT

The Efficacy of Azithromycin in Treating Children With Non Cystic Fibrosis Bronchiectasis

Condition:   Non Cystic Fibrosis Bronchiectasis in Children
Intervention:   Drug: Azithromycin
Sponsor:   Assistance Publique Hopitaux De Marseille
Unknown status

Tue, 25 Aug 2015 12:00:00 EDT

Effect of Using Azithromycin Versus Placebo With Dexamethasone in Prevention of Post-spinal Nausea and Vomiting.

Condition:   Post-operative Nausea and Vomiting
Interventions:   Drug: Oral Azithromycin tablet;   Drug: Intravenous dexamethasone
Sponsor:   Assiut University
Unknown status

Wed, 24 May 2017 12:00:00 EDT

AZISAST Study: AZIthromycin in Severe ASThma Study

Condition:   Asthma
Interventions:   Drug: Azithromycin 250 mg;   Drug: Placebo
Sponsors:   University Hospital, Ghent;   Agentschap voor Innovatie door Wetenschap en Technologie
Completed

Fri, 26 Sep 2008 12:00:00 EDT

Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease

Condition:   Sickle Cell Disease
Interventions:   Drug: Azithromycin;   Other: Placebo
Sponsor:   Vanderbilt University
Withdrawn

Wed, 09 Nov 2016 12:00:00 EST

Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes

Condition:   Preterm Premature Ruptured Membranes
Interventions:   Drug: Azithromycin;   Drug: Erythromycin
Sponsor:   Indiana University
Withdrawn

Fri, 16 Mar 2012 12:00:00 EDT

Azithromycin-Prevention in Labor Use Study (A-PLUS)

Conditions:   Maternal Death;   Maternal Infections Affecting Fetus or Newborn;   Neonatal SEPSIS;   Maternal Sepsis During Labor;   Neonatal Death;   Postpartum Sepsis
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   NICHD Global Network for Women's and Children's Health;   University of Alabama at Birmingham;   University Teaching Hospital, Lusaka, Zambia;   University of North Carolina, Chapel Hill;   Kinshasa School of Public Health;   University of Colorado, Denver;   Institute of Nutrition of Central America and Panama;   University of Virginia;   International Centre for Diarrhoeal Disease Research, Bangladesh;   Thomas Jefferson University;   Columbia University;   Aga Khan University;   Boston University;   Lata Medical Research Foundation, Nagpur;   Indiana University School of Medicine;   Moi Univeristy;   RTI International;   Bill and Melinda Gates Foundation;   KLE University's Jawaharlal Nehru Medical College
Recruiting

Tue, 12 Mar 2019 12:00:00 EDT

Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study

Condition:   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   NYU Langone Health
Completed

Wed, 23 Sep 2015 12:00:00 EDT

Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers

Conditions:   Bacterial Infections;   Eye Infections
Interventions:   Drug: AzaSite (azithromycin ophthalmic solution);   Drug: Vigamox (moxifloxacin hydrochloride ophthalmic solution)
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 18 Dec 2007 12:00:00 EST

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Condition:   Blepharoconjunctivitis
Interventions:   Drug: 1% Azithromycin and 0.1% Dexamethasone;   Drug: 1% Azithromycin;   Drug: 0.1% Dexamethasone
Sponsor:   Sun Pharma Global FZE
Withdrawn

Thu, 18 Sep 2008 12:00:00 EDT

Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.

Condition:   Malaria
Interventions:   Drug: azithromycin + artesunate;   Drug: artemether-lumefantrine
Sponsors:   London School of Hygiene and Tropical Medicine;   National Institute for Medical Research, Tanzania
Completed

Tue, 10 Jun 2008 12:00:00 EDT

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Condition:   Blepharoconjunctivitis
Interventions:   Drug: 1% Azithromycin and 0.1% Dexamethasone;   Drug: 1% Azithromycin;   Drug: 0.1% Dexamethasone
Sponsor:   Sun Pharma Global FZE
Completed

Fri, 21 Dec 2007 12:00:00 EST

A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria

Condition:   Falciparum Malaria
Intervention:   Drug: Azithromycin plus chloroquine
Sponsor:   Pfizer
Completed

Fri, 27 Jan 2006 12:00:00 EST

Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.

Condition:   Malaria
Interventions:   Drug: Azithromycin plus Chloroquine;   Drug: Mefloquine
Sponsor:   Pfizer
Completed

Wed, 23 Aug 2006 12:00:00 EDT

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Macrolide Antibiotic (Azithromycin);   Drug: Placebo
Sponsors:   University of Minnesota;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Mon, 15 May 2006 12:00:00 EDT

Kebele Elimination of Trachoma for Ocular Health

Condition:   Trachoma
Intervention:   Drug: Azithromycin
Sponsors:   University of California, San Francisco;   National Eye Institute (NEI);   Eyu-Ethiopia;   Bahir Dar University
Not yet recruiting

Tue, 07 Nov 2017 12:00:00 EST

Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial

Condition:   Bacterial Infections
Interventions:   Drug: Azithromycin 500 mg Oral Tablet x 4;   Drug: Matching Placebo
Sponsors:   Murdoch Childrens Research Institute;   Ministry of Health, Fiji
Recruiting

Wed, 24 Apr 2019 12:00:00 EDT

Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions

Condition:   Infections
Interventions:   Drug: Azithromycin for Oral Suspension 200mg/5mL Eon Pharma, LLC;   Drug: Zithromax (azithromycin for oral suspension) 200mg/5mL Pfizer
Sponsor:   Sandoz
Completed

Mon, 06 Apr 2009 12:00:00 EDT

Bronchiectasis and Long Term Azithromycin Treatment

Conditions:   Bronchiectasis;   Inflammation
Interventions:   Drug: Azithromycin;   Other: Placebo
Sponsor:   W.G.Boersma
Completed

Fri, 22 Dec 2006 12:00:00 EST

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

Condition:   Blepharitis
Interventions:   Drug: Tobradex ST;   Drug: Azasite
Sponsor:   Alcon Research
Completed

Tue, 13 Apr 2010 12:00:00 EDT

Comparison of Two Different Doses of Azithromycin for Treatment of Yaws

Condition:   Yaws
Intervention:   Drug: Azithromycin
Sponsors:   London School of Hygiene and Tropical Medicine;   World Health Organization;   Centers for Disease Control and Prevention;   Kwame Nkrumah University of Science and Technology;   Barcelona Institute for Global Health;   Papua New Guinea Institute of Medical Research;   Ghana Health Services;   Noguchi Memorial Institute for Medical Research;   Papua New Guinea National Department of Health;   University of Health and Allied Sciences, Ho, Volta Region, Ghana
Completed

Mon, 26 Jan 2015 12:00:00 EST

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

Condition:   Healthy
Interventions:   Drug: cefdinir (Omnicef);   Drug: azithromycin
Sponsor:   Abbott
Completed

Thu, 27 Mar 2008 12:00:00 EDT

Lipids of the Human Tear Film and Their Effect on Tear Stability

Condition:   Blepharitis
Interventions:   Drug: doxycycline;   Drug: azithromycin
Sponsor:   University of Louisville
Completed

Fri, 05 Dec 2008 12:00:00 EST

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)

Condition:   Coronavirus Infections
Interventions:   Drug: Hydroxychloroquine Oral Product;   Drug: Hydroxychloroquine + azithromycin
Sponsors:   Hospital do Coracao;   Hospital Israelita Albert Einstein;   Hospital Sirio-Libanes;   Brazilian Research In Intensive Care Network;   EMS
Active, not recruiting

Thu, 26 Mar 2020 12:00:00 EDT

Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection

Conditions:   Endometritis;   Wound Infection;   Abscess;   Surgical Site Infection
Interventions:   Drug: Azithromycin and standard of care;   Drug: Placebo and standard of care
Sponsors:   Alan Tita;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   University of Texas;   University of North Carolina;   Mission Hospital;   Ochsner Health System;   The University of Texas Health Science Center, Houston;   Columbia University;   University of Utah;   University of Mississippi Medical Center
Completed

Fri, 05 Nov 2010 12:00:00 EDT

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Conditions:   Lung Infection;   Mycobacterium Avium Complex
Interventions:   Drug: Clarithromycin 1000 MG;   Drug: Azithromycin 250 mg;   Drug: Rifampicin;   Drug: Ethambutol
Sponsor:   Centre Hospitalier Universitaire, Amiens
Recruiting

Wed, 02 Aug 2017 12:00:00 EDT

Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients

Condition:   Covid-19
Interventions:   Drug: Hydroxychloroquine and Azithromycin;   Dietary Supplement: Azinc
Sponsor:   Assistance Publique - Hôpitaux de Paris
Withdrawn

Fri, 01 May 2020 12:00:00 EDT

Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia

Condition:   Trichiasis
Interventions:   Drug: azithromycin;   Drug: topical tetracycline
Sponsors:   Johns Hopkins University;   National Eye Institute (NEI);   Project ORBIS
Completed

Tue, 04 Jul 2006 12:00:00 EDT

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

Condition:   Covid19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Other: Placebo Tablet;   Other: Placebo capsules
Sponsor:   Hamad Medical Corporation
Completed

Thu, 16 Apr 2020 12:00:00 EDT

An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates

Conditions:   Ureaplasma;   Bacterial Infection
Intervention:   Drug: Azithromycin
Sponsors:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Pediatric Pharmacology Research Units Network;   Children's Hospital of Michigan
Completed

Fri, 26 Sep 2008 12:00:00 EDT

Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis

Condition:   Gastroparesis
Interventions:   Drug: Erythromycin;   Drug: Azithromycin
Sponsors:   University of Florida;   Metabolic Solutions Inc.
Terminated

Fri, 25 Mar 2011 12:00:00 EDT

TINN2: Treat Infection in NeoNates 2

Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   Inserm-Transfert (IT);   University of Liverpool;   Cardiff University;   University of Nottingham;   Erasmus Medical Center;   Heinrich-Heine-Universität Düsseldorf (UDUS);   Assistance Publique - Hôpitaux de Paris;   Mario Negri Institute (IRFMN);   Advanced Biological Laboratories ABL (ABL SA);   Simcyp Limited (SimCyp);   Only For Children Pharmaceuticals;   University of Ulm;   Karolinska Institutet;   Centre Hospitalier Chrétien (CHC);   Semmelweis University
Withdrawn

Tue, 04 Nov 2014 12:00:00 EST

Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients

Condition:   Community-acquired Pneumonia
Interventions:   Drug: Azithromycin;   Drug: Levofloxacin
Sponsor:   Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Unknown status

Mon, 09 Nov 2015 12:00:00 EST

A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic

Condition:   COVID
Interventions:   Drug: Azithromycin 500 milligram (mg) oral Tablet;   Drug: Placebo
Sponsor:   Prof. Dr. Matthias Preusser
Recruiting

Thu, 30 Apr 2020 12:00:00 EDT

Partnership for Rapid Elimination of Trachoma

Condition:   Trachoma
Intervention:   Drug: Azithromycin
Sponsors:   Johns Hopkins University;   Bill and Melinda Gates Foundation
Completed

Tue, 18 Nov 2008 12:00:00 EST

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

Conditions:   SARS-CoV-2;   COVID-19
Interventions:   Combination Product: Hydroxychloroquine Sulfate + Azithromycin;   Drug: Hydroxychloroquine Sulfate
Sponsor:   Rutgers, The State University of New Jersey
Active, not recruiting

Tue, 07 Apr 2020 12:00:00 EDT

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine Sulfate;   Drug: Azithromycin Tablets
Sponsor:   Azidus Brasil
Suspended

Wed, 01 Apr 2020 12:00:00 EDT

Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection

Conditions:   Chlamydia Trachomatis Infection;   Vaginal Infection;   Anal Infection
Interventions:   Drug: azithromycin;   Drug: doxycycline
Sponsors:   University Hospital, Bordeaux;   USC EA 3671 Infections humaines à mycoplasmes et à chlamydiae
Unknown status

Tue, 22 May 2018 12:00:00 EDT

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19

Conditions:   SARS-CoV-2 Pneumonia;   COVID-19
Interventions:   Drug: Hydroxychloroquine 200 Mg Oral Tablet;   Drug: Azithromycin 250 MG
Sponsor:   Centre Hôpital Universitaire Farhat Hached
Not yet recruiting

Thu, 28 May 2020 12:00:00 EDT

A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

Condition:   Autoimmune Diseases
Interventions:   Drug: Azithromycin - 250 mg;   Drug: Azithromycin - 1000 mg;   Drug: Azithromycin - 250 mg every other day for 3 weeks
Sponsor:   GlaxoSmithKline
Completed

Mon, 15 Aug 2011 12:00:00 EDT

Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit

Condition:   COVID-19 Pneumonia
Interventions:   Combination Product: Azithromycin with amoxicillin/clavulanate;   Drug: amoxicillin/clavulanate
Sponsor:   Nantes University Hospital
Not yet recruiting

Mon, 27 Apr 2020 12:00:00 EDT

BACE Trial Substudy 2 - FarmEc Substudy

Condition:   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   Wim Janssens
Completed

Thu, 31 Jul 2014 12:00:00 EDT

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Conditions:   COVID19;   SARS-CoV-2 Infection
Interventions:   Drug: Sarilumab;   Drug: Azithromycin;   Drug: Hydroxychloroquine
Sponsor:   Assistance Publique - Hôpitaux de Paris
Suspended

Fri, 10 Apr 2020 12:00:00 EDT

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

Conditions:   Asthma;   Wheezing
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of Arizona;   University of Utah;   Emory University;   Morgan Stanley Children's Hospital;   University of Pittsburgh;   Children's Hospital and Health System Foundation, Wisconsin;   Children's Hospital of Philadelphia;   Children's Hospital Medical Center, Cincinnati;   Boston Children's Hospital
Not yet recruiting

Wed, 16 Dec 2020 12:00:00 EST

Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh

Condition:   Uncomplicated Falciparum Malaria
Interventions:   Drug: azithromycin plus artesunate;   Drug: Artesunate
Sponsors:   Medical University of Vienna;   International Centre for Diarrhoeal Disease Research, Bangladesh;   Armed Forces Research Institute of Medical Sciences, Thailand
Completed

Tue, 25 Jul 2006 12:00:00 EDT

The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers

Condition:   Interaction
Interventions:   Drug: BCT197;   Drug: Azithromycin
Sponsor:   Mereo BioPharma
Completed

Thu, 06 Oct 2016 12:00:00 EDT

To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

Condition:   Infection
Interventions:   Drug: Azithromycin Monohydrate 600 mg Tablets;   Drug: Zithromax (azithromycin dihydrate) 600 mg Tablets
Sponsor:   Sandoz
Completed

Thu, 19 Mar 2009 12:00:00 EDT

Azithromycin Combination Therapy for the Treatment of Severe Malaria

Condition:   Falciparum Malaria
Interventions:   Drug: Artesunate;   Drug: Azithromycin + Artesunate
Sponsors:   Medical University of Vienna;   International Centre for Diarrhoeal Disease Research, Bangladesh
Completed

Wed, 15 Jun 2011 12:00:00 EDT

Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea

Condition:   Diarrhea
Interventions:   Drug: Azithromycin 500 mg;   Drug: Azithromycin 1000 mg;   Drug: Loperamide;   Other: Placebo
Sponsor:   The University of Texas Health Science Center, Houston
Completed

Thu, 03 Aug 2006 12:00:00 EDT

A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine

Condition:   Malaria
Interventions:   Drug: Fixed combination of Azithromycin and Chloroquine;   Drug: Azithromycin and Chloroquine
Sponsor:   Pfizer
Completed

Mon, 16 Feb 2009 12:00:00 EST

Scandinavian Cystic Fibrosis Azithromycin Study

Condition:   Cystic Fibrosis
Interventions:   Drug: Study medication, azithromycin or placebo;   Drug: Azithromycin or placebo tablets
Sponsors:   Rigshospitalet, Denmark;   Cystic Fibrosis Foundation
Completed

Fri, 15 Dec 2006 12:00:00 EST

Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions

Condition:   Infection
Interventions:   Drug: Azithromycin Monohydrate 600mg Tablets Geneva Pharmaceuticals;   Drug: Zithromax (Azithromycin Dihydrate) 600mg Tablets Pfizer Inc.
Sponsor:   Sandoz
Completed

Fri, 20 Mar 2009 12:00:00 EDT

Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes

Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus;   Metabolic Disease;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Juvenile Diabetes;   Insulin Dependent Diabetes;   Type 1 Diabetes Mellitus;   Inflammation;   Diet Modification
Interventions:   Drug: Azithromycin Monohydrate;   Drug: Insulin Lispro;   Behavioral: Dietician support
Sponsors:   Uppsala University;   Göteborg University
Recruiting

Mon, 24 Sep 2018 12:00:00 EDT

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

Condition:   Gonorrhea
Interventions:   Drug: Gepotidacin;   Drug: Ceftriaxone;   Drug: Azithromycin
Sponsor:   GlaxoSmithKline
Recruiting

Mon, 08 Jul 2019 12:00:00 EDT

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

Conditions:   Gastro Intestinal Bleeding;   Upper Gastrointestinal Bleeding
Interventions:   Drug: Azithromycin Injection;   Drug: Metoclopramide Injectable Solution;   Drug: Sodium chloride 0.9%
Sponsor:   Waihong Chung
Recruiting

Fri, 15 Feb 2019 12:00:00 EST

Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

Condition:   Healthy
Interventions:   Drug: Azithromycin Tablets 600 mg;   Drug: Zithromax® Tablets 600 mg
Sponsor:   Mylan Pharmaceuticals
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

Condition:   Healthy
Interventions:   Drug: Azithromycin Tablets 600 mg;   Drug: Zithromax® Tablets 600 mg
Sponsor:   Mylan Pharmaceuticals
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults

Condition:   Malaria
Interventions:   Drug: Fosmidomycin;   Drug: Azithromycin
Sponsors:   Jomaa Pharma GmbH;   Mahidol University;   Thammasat University
Unknown status

Thu, 03 Nov 2011 12:00:00 EDT

Nepal Elimination of Trachoma Study

Condition:   Trachoma
Intervention:   Drug: Azithromycin
Sponsors:   University of California, San Francisco;   National Eye Institute (NEI)
Withdrawn

Thu, 26 Jun 2014 12:00:00 EDT

Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia

Condition:   Community-Acquired Pneumonia
Interventions:   Drug: Azithromycin SR;   Drug: Amoxiclav
Sponsor:   Pfizer
Terminated

Tue, 15 Dec 2009 12:00:00 EST

A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children

Conditions:   Malaria;   Respiratory Infections
Interventions:   Drug: Sulphadoxine-Pyrimethamine+ Amodiaquine+ Azithromycin;   Drug: Sulphadoxine-pyrimethamine + amodiaquine + placebo azithromycin
Sponsors:   London School of Hygiene and Tropical Medicine;   Malaria Research and Training Center, Bamako, Mali;   Institut de Recherche en Sciences de la Sante, Burkina Faso
Completed

Thu, 07 Aug 2014 12:00:00 EDT

Azithromycin/Bicillin Syphilis

Condition:   Syphilis
Interventions:   Drug: Azithromycin;   Drug: Benzathine Penicillin;   Drug: Doxycycline
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Thu, 07 Mar 2002 12:00:00 EST

A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

Condition:   Posterior Blepharoconjunctivitis
Intervention:   Drug: Azithromycin ophthalmic solution, 1%
Sponsor:   Merck Sharp & Dohme Corp.
Terminated

Wed, 13 Oct 2010 12:00:00 EDT

Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Condition:   Malignant Hematological Diseases
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Active, not recruiting

Wed, 09 Oct 2013 12:00:00 EDT

A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects

Condition:   Malaria Prophylaxis
Interventions:   Drug: azithromycin (AZ) microsphere;   Drug: test chloroquine (CQ) formulation;   Drug: azithromycin (AZ);   Drug: chloroquine (CQ)
Sponsor:   Pfizer
Completed

Thu, 08 Apr 2010 12:00:00 EDT

A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia

Condition:   Influenza
Interventions:   Biological: Nasovac-S;   Drug: Azithromycin
Sponsors:   London School of Hygiene and Tropical Medicine;   University of Edinburgh;   Public Health England;   University of Oxford;   National Institute for Public Health and the Environment (RIVM)
Completed

Fri, 25 Nov 2016 12:00:00 EST

Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM

Condition:   Anal Chlamydia Infection
Interventions:   Drug: Azithromycin;   Drug: Doxycycline;   Other: Placebo
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 01 Aug 2018 12:00:00 EDT

Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection

Condition:   SARS-CoV-2
Interventions:   Other: Standard of care;   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsor:   Duke University
Terminated

Mon, 06 Apr 2020 12:00:00 EDT

Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa

Condition:   Bronchiectasis
Intervention:   Drug: Azithromycin
Sponsor:   Jin-Fu Xu
Completed

Wed, 08 Jul 2015 12:00:00 EDT

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Conditions:   COVID-19;   SARS-CoV 2
Interventions:   Drug: Hydroxychloroquine (HCQ);   Drug: Azithromycin (Azithro);   Drug: Placebo for Hydroxychloroquine;   Drug: Placebo for Azithromycin
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Teva Pharmaceuticals Industries LTD
Terminated

Wed, 22 Apr 2020 12:00:00 EDT

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Conditions:   Coronavirus Infections;   SARS-CoV 2;   SARS (Severe Acute Respiratory Syndrome);   Pulmonary Disease
Interventions:   Drug: Hydroxychloroquine Sulfate;   Drug: Hydroxychloroquine Sulfate + Azythromycin
Sponsors:   Apsen Farmaceutica S.A.;   Federal University of São Paulo
Withdrawn

Fri, 24 Apr 2020 12:00:00 EDT

Treatment of ppROM With Erythromycin vs. Azithromycin Trial

Condition:   Preterm Premature Rupture of Membranes (PPROM)
Interventions:   Drug: Azithromycin;   Drug: Erythromycin;   Drug: Ampicillin;   Drug: Amoxicillin
Sponsor:   The University of Texas Medical Branch, Galveston
Recruiting

Thu, 23 Feb 2017 12:00:00 EST

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

Condition:   Childhood Asthma With Acute Exacerbation
Interventions:   Drug: Azithromycin Oral Liquid Product;   Other: Placebo mixture
Sponsor:   Copenhagen Studies on Asthma in Childhood
Not yet recruiting

Tue, 31 Aug 2021 12:00:00 EDT

Effect of Azithromycin on Oesophageal Hypomotility

Condition:   Esophageal Motility Disorders
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsor:   JAFAR JAFARI
Completed

Fri, 07 Oct 2011 12:00:00 EDT

Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex

Condition:   Cystic Fibrosis
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Unity Health Toronto;   Cystic Fibrosis Foundation;   Pfizer
Unknown status

Fri, 03 Mar 2006 12:00:00 EST

Antibiotic Treatment Trial for the PANDAS/PANS Phenotype

Conditions:   PANS;   PANDAS;   Obsessive Compulsive Disorder (OCD)
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of South Florida;   Massachusetts General Hospital
Completed

Tue, 12 Jun 2012 12:00:00 EDT

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

Condition:   Coronavirus Infection
Interventions:   Drug: Hydroxychloroquine Sulfate;   Drug: Azithromycin;   Drug: Chloroquine Sulfate
Sponsor:   Washington University School of Medicine
Terminated

Fri, 10 Apr 2020 12:00:00 EDT

Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children

Conditions:   Chronic Lung Disease;   HIV Infection
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   London School of Hygiene and Tropical Medicine;   Biomedical Research and Training Institute, Zimbabwe;   Malawi-Liverpool-Wellcome Trust Clinical Research Programme;   University of Tromso;   University of Cape Town;   University of Oxford
Completed

Fri, 24 Apr 2015 12:00:00 EDT

EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA

Condition:   Sars-CoV-2, Community-Acquired Pneumonia,COVID-19
Interventions:   Drug: Hydroxychloroquine and azithromycin treatment arm.;   Drug: Hydroxychloroquine;   Drug: Control arm
Sponsor:   University Hospital, Strasbourg, France
Withdrawn

Wed, 15 Apr 2020 12:00:00 EDT

Proactive Care of Ambulatory COVID19 Patients

Conditions:   Covid19;   Azithromycin;   Ambulatory
Interventions:   Other: consultation;   Drug: Azithromycin
Sponsor:   Centre Hospitalier Universitaire, Amiens
Not yet recruiting

Fri, 01 May 2020 12:00:00 EDT

Asymptomatic COVID-19 Trial

Condition:   SARS-CoV-2 Infection
Interventions:   Drug: Hydroxychloroquine sulfate &Azithromycin;   Drug: Placebo
Sponsor:   Rutgers, The State University of New Jersey
Withdrawn

Tue, 05 May 2020 12:00:00 EDT

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

Condition:   Urethritis
Interventions:   Drug: Tinidazole;   Other: Placebo;   Drug: Doxycycline;   Drug: Azithromycin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Mon, 08 May 2006 12:00:00 EDT

The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children

Conditions:   Azithromycin Adverse Reaction;   Covid19;   Long QT Syndrome
Intervention:   Drug: Azithromycin
Sponsor:   Kayseri City Hospital
Completed

Thu, 07 Jan 2021 12:00:00 EST

Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level

Condition:   Lower Respiratory Tract Infection
Interventions:   Drug: Azithromycin;   Other: Placebo;   Device: VIDAS B.R.A.H.M.S Procalcitonin Test (PCT)
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Terminated

Tue, 14 Nov 2017 12:00:00 EST

Tripartite International Research for the Elimination of Trachoma

Conditions:   Trachoma;   Chlamydia
Intervention:   Drug: mass treatment with oral azithromycin
Sponsor:   University of California, San Francisco
Completed

Wed, 15 Sep 2010 12:00:00 EDT

Nutritional Support for Lactating Women and Azithromycin to Infants - Mumta Lactating Women Trial

Condition:   Undernutrition
Interventions:   Dietary Supplement: Balanced energy-protein (BEP);   Drug: Azithromycin
Sponsors:   Vital Pakistan Trust;   Aga Khan University
Completed

Thu, 21 Jun 2018 12:00:00 EDT

Intestinal Microbiome Post-Azythromycin/Albendazole Treatment

Condition:   Helminth Infection
Interventions:   Drug: Azithromycin;   Drug: Albendazole;   Drug: Delayed treatment
Sponsor:   University of California, San Francisco
Withdrawn

Thu, 26 Jan 2017 12:00:00 EST

A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects

Condition:   Fasting
Intervention:   Drug: Azithromycin
Sponsor:   PT Novell Pharmaceutical Laboratories
Completed

Fri, 18 May 2012 12:00:00 EDT

Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

Condition:   COVID-19 Infection
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Drug: Telmisartan
Sponsor:   University Hospital, Strasbourg, France
Recruiting

Fri, 24 Apr 2020 12:00:00 EDT

A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

Condition:   Pneumonia, Community-Acquired
Intervention:   Drug: Azithromycin SR
Sponsor:   Pfizer
Completed

Fri, 04 Aug 2006 12:00:00 EDT

A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis

Condition:   Upper Respiratory Tract Infection
Intervention:   Drug: Azithromycin SR
Sponsor:   Pfizer
Completed

Sun, 29 Oct 2006 12:00:00 EDT

A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases

Condition:   Acute Bronchitis
Intervention:   Drug: Azithromycin SR
Sponsor:   Pfizer
Completed

Fri, 04 Aug 2006 12:00:00 EDT

Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial

Conditions:   COVID-19;   Respiratory Failure
Interventions:   Drug: Azithromycin;   Drug: Hydroxychloroquine;   Drug: Placebo
Sponsors:   Frantisek Duska, MD, PhD;   Masaryk Hospital Usti nad Labem;   University Hospital Pilsen;   The Faculty Hospital Na Bulovce;   St. Anne's University Hospital Brno, Czech Republic;   University Hospital, Motol;   General University Hospital, Prague;   University Hospital Olomouc
Terminated

Thu, 09 Apr 2020 12:00:00 EDT

The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease

Conditions:   Cat-scratch Disease;   Bartonella Infections
Interventions:   Drug: prednison and azithromycin;   Drug: prednison, azithromycin;   Drug: prednison, Azenil
Sponsor:   Tel-Aviv Sourasky Medical Center
Unknown status

Thu, 10 Nov 2011 12:00:00 EST

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

Condition:   Uncomplicated Urogenital Gonorrhea
Interventions:   Drug: solithromycin;   Drug: ceftriaxone;   Drug: azithromycin
Sponsors:   Melinta Therapeutics, Inc.;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 06 Aug 2014 12:00:00 EDT

Macrolide Maintenance Therapy in Chronic Obstructive Pulmonary Disease

Condition:   COPD
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   R.S. Djamin;   Erasmus Medical Center;   Stichting Solong;   Amphia Hospital
Completed

Mon, 28 Sep 2009 12:00:00 EDT

Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19

Conditions:   Virus Diseases;   Infection Viral;   Corona Virus Infection
Interventions:   Drug: Azithromycin;   Drug: Hydroxychloroquine;   Drug: Placebo oral tablet
Sponsor:   Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Terminated

Thu, 26 Mar 2020 12:00:00 EDT

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus

Condition:   COVID - 19
Interventions:   Drug: hydroxychloroquine in combination with camostat mesylate;   Drug: Hydroxychloroquine in combination of Azithromycin
Sponsor:   Sheba Medical Center
Recruiting

Tue, 21 Apr 2020 12:00:00 EDT

Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients

Condition:   COVID-19 Patients
Intervention:   Drug: HCQ & AZ vs HCQ+SIR
Sponsor:   King Hussein Cancer Center
Not yet recruiting

Tue, 05 May 2020 12:00:00 EDT

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)

Condition:   Blepharitis
Interventions:   Drug: Azithromycin ophthalmic solution, 1%;   Drug: Vehicle
Sponsor:   Merck Sharp & Dohme Corp.
Terminated

Tue, 04 Jan 2011 12:00:00 EST

Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients

Condition:   Covid19
Interventions:   Combination Product: Hydroxychloroquine/Azithromycine;   Combination Product: Quinquina-Stevia/Azythromycin;   Combination Product: 4Plants/Azythromycin
Sponsor:   Institute for Research and Development of Medicinal and Food Plants of Guinea
Enrolling by invitation

Thu, 06 Aug 2020 12:00:00 EDT

Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis

Conditions:   Bronchiectasis;   Pulmonary Disease;   Chronic Bronchitis
Interventions:   Drug: azithromycin and fluticasone;   Drug: fluticasone and azithromycin
Sponsor:   University of Milan
Terminated

Mon, 03 Sep 2007 12:00:00 EDT

Azithromycin - Ivermectin Mass Drug Administration for Skin Disease

Conditions:   Scabies;   Yaws;   Impetigo
Interventions:   Drug: Ivermectin;   Drug: Azithromycin;   Drug: Permethrin
Sponsors:   London School of Hygiene and Tropical Medicine;   Atoifi Adventist Hospital, Solomon Islands;   Kirby Institute;   Murdoch Childrens Research Institute
Completed

Tue, 17 May 2016 12:00:00 EDT

Chronic Airway Disease, Mucus Rheology and Exacerbations

Condition:   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Azithropycin according to symptoms;   Drug: Azithromycin according to rheology
Sponsor:   University Hospital, Montpellier
Not yet recruiting

Thu, 09 Apr 2020 12:00:00 EDT

Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat

Condition:   Tonsillitis
Interventions:   Drug: Zithromax;   Drug: Clamoxyl
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )

Conditions:   Trachoma;   Yaws;   Lymphatic Filariases;   Scabies;   Strongyloidiasis
Interventions:   Drug: Albendazole on Day 1;   Drug: Ivermectin on Day 1;   Drug: Diethylcarbamazine on day 1;   Drug: Azithromycin on Day 1;   Drug: Azithromycin on Day 8
Sponsors:   Lihir Medical Centre;   London School of Hygiene and Tropical Medicine
Completed

Tue, 18 Sep 2018 12:00:00 EDT

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.

Condition:   Asthmatic Patients
Intervention:   Drug: azithromycin
Sponsor:   Universitaire Ziekenhuizen Leuven
Unknown status

Wed, 20 Oct 2010 12:00:00 EDT

Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia

Condition:   Community-Acquired Pneumonia
Intervention:   Drug: Azithromycin microspheres 2.0 single dose
Sponsor:   Pfizer
Completed

Wed, 31 Aug 2005 12:00:00 EDT

A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis

Condition:   Bronchitis, Chronic
Interventions:   Drug: Amoxicillin/clavulinic acid;   Drug: Azithromycin
Sponsor:   Pfizer
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries

Conditions:   Endometritis;   Cesarean Section; Infection;   Wound Infection
Interventions:   Drug: Azithromycin 500 mg;   Drug: Mefoxin 2g
Sponsor:   RWJ Barnabas Health at Jersey City Medical Center
Unknown status

Thu, 23 May 2019 12:00:00 EDT

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Condition:   Intermittent Preventive Treatment In Pregnancy (IPTp)
Interventions:   Drug: Azithromycin plus chloroquine;   Drug: sulfadoxine-pyrimethamine
Sponsors:   Pfizer;   London School of Hygiene and Tropical Medicine;   Medicines for Malaria Venture
Terminated

Tue, 13 Apr 2010 12:00:00 EDT

Ciprofloxacin Multiple Dose for Adult Cholera

Condition:   Cholera
Interventions:   Drug: Ciprofloxacin;   Drug: Azithromycin
Sponsor:   International Centre for Diarrhoeal Disease Research, Bangladesh
Completed

Tue, 26 Aug 2008 12:00:00 EDT

Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin

Conditions:   Trachoma;   Lymphatic Filariases
Interventions:   Drug: Administration of Albendazole on Day 1;   Drug: Administration of Ivermectin on Day 1;   Drug: Administration of Azithromycin on Day 1;   Drug: Administration of Azithromycin on Day 15
Sponsors:   London School of Hygiene and Tropical Medicine;   Armauer Hansen Research Institute, Ethiopia;   Federal Minstry of Health of Ethiopia
Not yet recruiting

Wed, 27 Jun 2018 12:00:00 EDT

Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia

Condition:   Community-Acquired Pneumonia (CAP)
Interventions:   Drug: IV azithromycin;   Drug: ceftriaxone;   Drug: oral azithromycin;   Drug: IV levofloxacin;   Drug: oral levofloxacin
Sponsor:   Pfizer
Completed

Mon, 06 May 2002 12:00:00 EDT

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

Condition:   Pneumonia
Interventions:   Drug: clarithromycin extended release (ER);   Drug: azithromycin SR
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Microorganism in Overactive Bladder Patients

Condition:   Overactive Bladder
Intervention:   Drug: azithromycin, doxycycline
Sponsor:   Samsung Medical Center
Completed

Mon, 20 Apr 2009 12:00:00 EDT

A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children

Condition:   Tonsillitis
Interventions:   Drug: amoxicillin;   Drug: azithromycin SR
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Conditions:   COVID19;   Hematologic Malignancy
Interventions:   Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil];   Drug: Azithromycin 250 MG Oral Capsule;   Drug: Placebo oral tablet;   Drug: Placebo oral capsule
Sponsor:   Institut de cancérologie Strasbourg Europe
Withdrawn

Mon, 18 May 2020 12:00:00 EDT

Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities

Condition:   Chlamydial Infection
Interventions:   Drug: Azithromycin;   Drug: Doxycycline
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 18 Sep 2009 12:00:00 EDT

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections

Conditions:   Respiratory Tract Infections;   Chronic Bronchitis;   Pneumonia
Interventions:   Drug: Telithromycin;   Drug: Azithromycin
Sponsor:   Sanofi
Terminated

Mon, 22 Aug 2005 12:00:00 EDT

Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchiolitis Obliterans After Bone Marrow Transplantation

Conditions:   Bronchiolitis Obliterans;   Bone Marrow Transplantation
Interventions:   Drug: Azithromycin;   Drug: Placebo tablet
Sponsors:   Hospital Authority, Hong Kong;   The University of Hong Kong;   Pfizer
Completed

Mon, 26 Nov 2007 12:00:00 EST

Antibiotics for Children With Severe Diarrhoea

Condition:   Diarrhea
Interventions:   Drug: Azithromycin;   Other: Placebo
Sponsors:   World Health Organization;   International Centre for Diarrhoeal Disease Research, Bangladesh;   Center for Public Health Kinetics;   Kenya Medical Research Institute;   University of Washington;   Malawi-Liverpool-Wellcome Trust Clinical Research Programme;   University of Liverpool;   Centre pour le developpement des vaccines, Mali;   University of Maryland, College Park;   Aga Khan University;   Muhimbili University of Health and Allied Sciences;   Boston Children's Hospital
Completed

Wed, 26 Apr 2017 12:00:00 EDT

Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis

Condition:   Endometritis
Interventions:   Drug: Azithromycin;   Drug: Cefazolin
Sponsor:   University of Missouri, Kansas City
Withdrawn

Tue, 06 Nov 2012 12:00:00 EST

Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19

Condition:   COVID
Interventions:   Drug: Ivermectin;   Drug: Azithromycin;   Drug: Cholecalciferol
Sponsor:   Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Recruiting

Fri, 22 May 2020 12:00:00 EDT

Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications

Condition:   Healthy Volunteer
Intervention:   Drug: Levofloxacin; Azithromycin
Sponsor:   Ortho-McNeil Janssen Scientific Affairs, LLC
Completed

Tue, 13 Jan 2009 12:00:00 EST

Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media

Condition:   Otitis Media
Intervention:   Drug: Zmax
Sponsor:   Pfizer
Completed

Thu, 03 Aug 2006 12:00:00 EDT

PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

Conditions:   Lymphatic Filariasis;   Yaws;   Trauma
Interventions:   Drug: Azithromycin;   Drug: Albendazole;   Drug: Ivermectin;   Drug: Diethylcarbamazine
Sponsor:   Lihir Medical Centre
Completed

Mon, 10 Sep 2018 12:00:00 EDT

The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease

Condition:   Chronic Lung Disease
Interventions:   Drug: Azithromycin;   Drug: placebo
Sponsor:   The University of Texas Health Science Center, Houston
Completed

Wed, 09 Sep 2015 12:00:00 EDT

Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso

Condition:   Child Development
Interventions:   Drug: Azithromycin;   Drug: Amoxicillin;   Drug: Cotrimoxazole;   Drug: Placebo
Sponsors:   University of California, San Francisco;   Centre de Recherche en Sante de Nouna, Burkina Faso;   Heidelberg University
Completed

Thu, 15 Jun 2017 12:00:00 EDT

Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT

Condition:   Chlamydia Trachomatis Infection
Interventions:   Diagnostic Test: C. trachomatis and N. gonorrhoeae;   Drug: Azithromycin;   Other: Partner notification and treatment
Sponsors:   University of North Carolina, Chapel Hill;   Southern Medical University, China
Recruiting

Tue, 05 Mar 2019 12:00:00 EST

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media

Condition:   Acute Otitis Media
Interventions:   Drug: cefdinir (Omnicef);   Drug: azithromycin
Sponsor:   Abbott
Completed

Thu, 27 Mar 2008 12:00:00 EDT

Treatment and Vaccine Development of Mycoplasma Pneumoniae

Condition:   Atypical Pneumonia
Interventions:   Drug: Doxycycline;   Drug: Azithromycin
Sponsor:   National Taiwan University Hospital
Recruiting

Thu, 11 Apr 2019 12:00:00 EDT

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

Conditions:   Pharyngitis;   Tonsillitis
Interventions:   Drug: azithromycin (Zithromax);   Drug: placebo;   Drug: azithromycin SR
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Treatment of Macrolide-resistant Mycoplasma Pneumoniae

Condition:   Pneumonia, Mycoplasma
Interventions:   Drug: Doxycycline;   Drug: Azithromycin
Sponsor:   National Taiwan University Hospital
Recruiting

Mon, 21 May 2018 12:00:00 EDT

A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections

Condition:   Acute Otitis Media
Interventions:   Drug: amoxicillin/clavulanate postassium (Augmentin ES-600);   Drug: azithromycin SR
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa

Condition:   Malaria, Falciparum
Interventions:   Drug: Azithromycin plus Chloroquine;   Drug: Artemether-lumefantrine
Sponsor:   Pfizer
Completed

Thu, 15 May 2008 12:00:00 EDT

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

Condition:   Malaria
Interventions:   Drug: Chloroquine-Azithromycin (CQ/AZ);   Drug: Chloroquine (CQ);   Drug: atovaquone-proguanil (Malarone®)
Sponsor:   U.S. Army Medical Research and Development Command
Withdrawn

Tue, 12 Sep 2017 12:00:00 EDT

Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial

Condition:   Respiratory Tract Infections
Interventions:   Drug: Levamisole and isoprinosine;   Drug: Azithromycin and hydroxychloroquine
Sponsor:   Cairo University
Not yet recruiting

Tue, 12 May 2020 12:00:00 EDT

Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis

Condition:   Blepharitis
Interventions:   Drug: povidone iodine;   Other: No Intervention;   Drug: Azithromycin;   Drug: tobramycin-dexmethasone;   Other: warm soaked eyelid wash
Sponsor:   Southern California Institute for Research and Education
Terminated

Thu, 22 Mar 2012 12:00:00 EDT


A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Conditions:   Mycobacterium Avium-intracellulare Infection;   HIV Infections
Intervention:   Drug: Azithromycin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

Condition:   Pharmacokinetics
Interventions:   Drug: azithromycin immediate release (Zithromax);   Other: placebo;   Drug: azithromycin SR
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Trachoma Elimination Follow-up

Conditions:   Trachoma;   Chlamydia
Intervention:   Drug: Mass treatment with oral azithromycin to an entire village
Sponsor:   University of California, San Francisco
Completed

Thu, 22 Sep 2005 12:00:00 EDT

Nepal Undifferentiated Febrile Illness Trial

Condition:   Undifferentiated Febrile Illness
Interventions:   Drug: Azithromycin;   Drug: Co-trimoxazole
Sponsors:   Oxford University Clinical Research Unit, Vietnam;   University of Oxford;   Wellcome Trust
Unknown status

Mon, 16 May 2016 12:00:00 EDT

Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children

Condition:   Typhoid Fever
Interventions:   Drug: Meropenem Injection;   Drug: Azithromycin Powder
Sponsor:   Ziauddin University
Completed

Wed, 06 Nov 2019 12:00:00 EST

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

Conditions:   Periodontal Diseases;   Antibiotics;   Pharmacokinetics
Interventions:   Drug: 3/d 500 mg Amoxicilline Sandoz plus 500 mg Flagyl for 7 days;   Drug: 3/d 500 mg Amoxicilline Sandoz plus 500 mg Flagyl for 3 days;   Drug: 1/d 500 mg Azithromycine Pfizer for 3 days
Sponsors:   University of Geneva, Switzerland;   University of Lausanne
Active, not recruiting

Thu, 17 Dec 2020 12:00:00 EST

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Drug: Zinc Sulfate;   Drug: Doxycycline
Sponsor:   St. Francis Hospital, New York
Completed

Fri, 01 May 2020 12:00:00 EDT

Efficacy of Combination Therapies for Gonorrhea Treatment

Condition:   Gonorrhoea
Interventions:   Drug: Azithromycin;   Drug: Gentamicin;   Drug: Gemifloxacin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 24 Jun 2009 12:00:00 EDT

Azithromycin and Coronary Events Study (ACES)

Conditions:   Coronary Disease;   Heart Diseases;   Myocardial Infarction;   Cardiovascular Diseases
Intervention:   Drug: azithromycin
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Conditions:   Trachoma;   Lymphatic Filariasis
Interventions:   Drug: azithromycin;   Drug: ivermectin;   Drug: albendazole;   Drug: placebo
Sponsor:   Emory University
Withdrawn

Fri, 19 Jul 2013 12:00:00 EDT

Zoliflodacin in Uncomplicated Gonorrhoea

Condition:   Gonorrhea
Interventions:   Drug: zoliflodacin;   Drug: ceftriaxone;   Drug: azithromycin
Sponsor:   Global Antibiotics Research and Development Partnership
Recruiting

Wed, 22 May 2019 12:00:00 EDT

Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication

Condition:   Yaws
Interventions:   Drug: R1-Total community treatment with azithromycin;   Drug: R2-Total community treatment with azithromycin;   Drug: R3-Total community treatment with azithromycin;   Drug: R2-Total targeted treatment with azithromycin;   Drug: R3-Total targeted treatment with azithromycin
Sponsors:   Lihir Medical Centre;   Barcelona Institute for Global Health;   National Department of Health of Papua New Guinea;   World Health Organization;   University of Masarykova;   Harvard School of Public Health
Completed

Fri, 06 Apr 2018 12:00:00 EDT

Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne

Condition:   Acne Vulgaris
Interventions:   Drug: Azithromycin microspheres;   Drug: minocycline-placebo capsules;   Drug: Azithromycin microspheres-placebo;   Drug: Minocycline capsules,
Sponsor:   Pfizer
Terminated

Wed, 25 Oct 2006 12:00:00 EDT

Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial

Condition:   Undernutrition
Interventions:   Dietary Supplement: Balanced-energy protein (BEP);   Drug: Azithromycin Tablets;   Drug: Choline Bitartrate;   Drug: Nicotinamide
Sponsors:   Vital Pakistan Trust;   Aga Khan University
Recruiting

Tue, 09 Jul 2019 12:00:00 EDT

BACE Trial Substudy 1 - PROactive Substudy

Condition:   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Azithromycin;   Device: Dynaport®;   Drug: Placebo
Sponsors:   Wim Janssens;   Pro-Active Medical Pty Ltd
Completed

Thu, 31 Jul 2014 12:00:00 EDT

PPROM Erythromycin Versus Azithromycin

Condition:   Preterm Premature Rupture of Membranes
Intervention:  
Sponsors:   University of Oklahoma;   Indiana University School of Medicine
Completed

Fri, 09 Sep 2011 12:00:00 EDT

Zithromax EV in Community-Acquired Pneumonia (CAP)

Condition:   Pneumonia
Interventions:   Drug: Azithromycin;   Drug: Ampicillin/sulbactam
Sponsor:   Pfizer
Completed

Mon, 29 Aug 2005 12:00:00 EDT

Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa

Condition:   Malaria, Falciparum
Interventions:   Drug: Azithromycin/Chloroquine;   Drug: Mefloquine
Sponsor:   Pfizer
Completed

Fri, 14 May 2004 12:00:00 EDT

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.

Conditions:   Asthma;   Wheezing
Interventions:   Drug: Azithromycin;   Drug: Prednisolone;   Other: Placebo Azithromycin;   Drug: Placebo Prednisolone
Sponsors:   Milton S. Hershey Medical Center;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Mon, 10 Jan 2011 12:00:00 EST

Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum

Condition:   Malaria, Falciparum
Interventions:   Drug: Azithromycin/Chloroquine;   Drug: Chloroquine
Sponsor:   Pfizer
Terminated

Fri, 14 May 2004 12:00:00 EDT

Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)

Conditions:   Tuberculosis;   Respiratory Tract Infections;   Pneumonia
Interventions:   Drug: Azithromycin;   Drug: Amoxicillin
Sponsors:   London School of Hygiene and Tropical Medicine;   University of Malawi College of Medicine
Completed

Mon, 04 Jun 2018 12:00:00 EDT

Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth

Conditions:   Malaria;   Sexually Transmitted Diseases;   Preterm Birth;   Pregnancy
Interventions:   Drug: Sulfadoxine-pyrimethamine treatment twice during pregnancy;   Drug: Sulfadoxine-pyrimethamine at 4-week intervals;   Drug: Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice
Sponsors:   Tampere University;   Academy of Finland;   Foundation for Paediatric Research, Finland
Active, not recruiting

Wed, 17 Aug 2005 12:00:00 EDT

Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination

Conditions:   Parasitic Diseases;   Bacterial Diseases
Intervention:   Drug: triple co administration at once of the combination of Albendazole + ivermectin + azithromycin
Sponsors:   Centre d'Appui à la lutte contre la Maladie;   International Trachoma Initiative
Completed

Thu, 26 Apr 2012 12:00:00 EDT

Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients

Condition:   Cancer & COVID 19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsor:   Gustave Roussy, Cancer Campus, Grand Paris
Recruiting

Fri, 10 Apr 2020 12:00:00 EDT

Bordetella Pertussis Colonisation Challenge Study

Condition:   Whooping Cough
Interventions:   Biological: Bordetella Pertussis B1917;   Drug: Azithromycin 500 mg;   Other: Sterile Saline
Sponsors:   University of Southampton;   Public Health England;   University Hospital Southampton NHS Foundation Trust
Recruiting

Fri, 23 Nov 2018 12:00:00 EST

Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

Condition:   Refractory Mycoplasma Pneumoniae Pneumonia
Interventions:   Drug: methylprednisolone;   Drug: azithromycin
Sponsor:   Chongqing Medical University
Terminated

Fri, 08 Oct 2010 12:00:00 EDT

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease

Condition:   Dry Eye Disease
Interventions:   Drug: Azithromycin Ophthalmic Solution, 1%;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Mon, 16 Nov 2009 12:00:00 EST

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)

Condition:   Contact Lens Dry Eye
Interventions:   Drug: azithromycin ophthalmic solution, 1%;   Drug: Visine® for Contacts®
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Fri, 16 Apr 2010 12:00:00 EDT

Targeted Therapy of Bronchiolitis Obliterans Syndrome

Condition:   Bronchiolitis Obliterans
Interventions:   Drug: fluticasone propionate;   Drug: montelukast sodium;   Drug: azithromycin
Sponsors:   Stephanie Lee;   National Cancer Institute (NCI)
Completed

Thu, 03 Mar 2011 12:00:00 EST

Efficacy of Macrolide Immunomodulation in Severe Sepsis.

Condition:   Systemic Inflammatory Response Syndrome
Intervention:   Other: Azithromycin on admission - not enrolled in the RCT
Sponsors:   VA Office of Research and Development;   Feinberg School of Medicine, Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Terminated

Wed, 02 Jul 2008 12:00:00 EDT

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Conditions:   Mycobacterium Avium Complex;   Nontuberculous Mycobacterium Infection
Interventions:   Drug: Azithromycin;   Drug: Ethambutol;   Drug: Rifampin
Sponsors:   Kevin Winthrop;   Patient-Centered Outcomes Research Institute;   National Jewish Health;   The University of Texas Health Science Center at Tyler;   University Health Network, Toronto;   New York University;   Medical University of South Carolina;   Mayo Clinic;   Louisiana State University Health Sciences Center in New Orleans;   University of California, San Diego;   Stanford University;   University of Kansas;   Vancouver Clinic;   University of California, San Francisco;   University of Washington;   Johns Hopkins University;   University of Miami;   Emory University;   University of Iowa;   University of North Carolina;   Temple University;   Loma Linda University;   Columbia University;   University of Wisconsin, Madison;   Northwell Health
Recruiting

Fri, 14 Sep 2018 12:00:00 EDT

OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis

Condition:   Cystic Fibrosis
Interventions:   Drug: azithromycin;   Drug: placebo;   Drug: Tobramycin solution for inhalation
Sponsors:   Bonnie Ramsey;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Tue, 04 Feb 2014 12:00:00 EST

Impact of Antichlamydial Treatment on the Rate of Preeclampsia

Condition:   Pre-Eclampsia
Interventions:   Drug: Azithromycin 1gm;   Other: PLACEBO
Sponsor:   Ain Shams Maternity Hospital
Unknown status

Mon, 31 Jul 2017 12:00:00 EDT

The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients

Conditions:   Mycobacterium Avium-intracellulare Infection;   HIV Infections
Interventions:   Drug: Clarithromycin;   Drug: Azithromycin;   Drug: Rifabutin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus

Condition:   SARS-CoV-2 Infection
Interventions:   Drug: hydroxychloroquine;   Drug: azithromycin;   Drug: hydroxychloroquine placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed

Tue, 14 Apr 2020 12:00:00 EDT

Zmax Compared to Augmentin in Sinusitis

Condition:   Sinusitis
Interventions:   Drug: Azithromycin Extended Release;   Drug: Amoxicillin/Clavulanate
Sponsor:   Pfizer
Completed

Tue, 22 Aug 2006 12:00:00 EDT

Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy

Condition:   Low Risk of Preterm Delivery
Interventions:   Other: -self-collected vaginal samples;   Drug: zithromax;   Other: usual practices
Sponsor:   Assistance Publique Hopitaux De Marseille
Completed

Tue, 11 Nov 2014 12:00:00 EST

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Conditions:   Infectious Disease;   SARS-CoV Infection;   Covid19
Interventions:   Drug: Favipiravir;   Drug: Azithromycin
Sponsors:   Ina-Respond;   Center for Research and Development of Health Resources and Services, National Institute of Health Research and Development (NIHRD), Indonesia
Recruiting

Tue, 03 Nov 2020 12:00:00 EST

Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   University of Alabama at Birmingham;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 25 Oct 2007 12:00:00 EDT

Healthy Patients & Effect of Antibiotics

Conditions:   Microbiota;   Anti-bacterial Agents
Interventions:   Drug: Levofloxacin;   Drug: Azithromycin;   Drug: Cefpodoxime
Sponsor:   Washington University School of Medicine
Active, not recruiting

Fri, 31 Mar 2017 12:00:00 EDT

Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment

Condition:   Covid19
Interventions:   Drug: Azithromycin / Ivermectin / Ribaroxaban / Paracetamol;   Drug: Azithromycin / Ribaroxaban / Paracetamol
Sponsors:   Gilberto Cruz Arteaga;   Coordinación de Investigación en Salud, Mexico
Completed

Thu, 17 Dec 2020 12:00:00 EST

Azithromycin Combination Therapy for Malaria

Condition:   Plasmodium Falciparum Malaria
Interventions:   Drug: Artesunate;   Drug: Azithromycin;   Drug: Quinine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Mon, 06 Mar 2006 12:00:00 EST

A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV

Conditions:   HIV;   Pregnancy Malaria;   Sexually Transmitted Infection
Interventions:   Drug: Azithromycin/TMPS;   Drug: Placebo/TMPS
Sponsor:   University of Alabama at Birmingham
Active, not recruiting

Tue, 13 Feb 2018 12:00:00 EST

The Effect of Preoperative Antibiotics on Peri-implant Healing

Condition:   Dental Implant Failed
Interventions:   Drug: Azithromycin;   Drug: Placebo oral tablet
Sponsors:   Université de Montréal;   Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting

Fri, 21 Feb 2020 12:00:00 EST

Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America

Condition:   Malaria, Falciparum
Interventions:   Drug: Azithromycin/Chloroquine;   Drug: Atovaquone/Proguanil
Sponsor:   Pfizer
Completed

Fri, 11 Jun 2004 12:00:00 EDT

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Indomethacin;   Drug: Zithromax Oral Product
Sponsors:   Perseverance Research Center, LLC;   Athena Medical Group
Recruiting

Tue, 14 Apr 2020 12:00:00 EDT

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali

Condition:   Stillbirths and Infant Mortality
Interventions:   Drug: Azithromycin to pregnant women;   Drug: Azithromycin to infants;   Other: Placebo to pregnant women;   Other: Placebo to infants;   Other: No intervention to pregnant women
Sponsors:   University of Maryland, Baltimore;   Bill and Melinda Gates Foundation
Recruiting

Wed, 10 Apr 2019 12:00:00 EDT

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

Condition:   Intubation Complication
Interventions:   Drug: Budesonide and Azithromycin;   Other: Placebo control of budesonide and azithromycin
Sponsor:   Vanderbilt University Medical Center
Recruiting

Wed, 16 Aug 2017 12:00:00 EDT

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

Conditions:   Trachoma;   Chlamydia Trachomatis
Interventions:   Drug: Azithromcyin;   Drug: Azithromycin
Sponsors:   University of California, San Francisco;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 20 Feb 2008 12:00:00 EST

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Condition:   Covid-19
Interventions:   Drug: HCQ;   Drug: HCQ+AZT;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Wed, 22 Apr 2020 12:00:00 EDT

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

Conditions:   Arthritis, Reactive;   Reiter Disease
Interventions:   Drug: Doxycycline and Rifampin;   Drug: Azithromycin and Rifampin;   Drug: Placebo
Sponsors:   University of South Florida;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed

Wed, 12 Jul 2006 12:00:00 EDT

Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia

Condition:   Malaria, Falciparum
Interventions:   Drug: Azithromycin/Chloroquine;   Drug: Sulfadoxine-Pyrimethamine/Chloroquine
Sponsor:   Pfizer
Terminated

Fri, 11 Jun 2004 12:00:00 EDT

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

Condition:   PLASMODIUM FALCIPARUM MALARIA
Interventions:   Drug: Azithromycin/Chloroquine;   Drug: Sulfadoxine-Pyrimethamine/Chloroquine
Sponsor:   Pfizer
Completed

Wed, 24 Dec 2003 12:00:00 EST

STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.

Condition:   Chronic Periodontitis
Interventions:   Drug: Scaling and root planing plus Azithromycin;   Drug: Scaling and root planing plus placebo
Sponsor:   Universidad del Valle, Colombia
Unknown status

Wed, 24 Jul 2013 12:00:00 EDT

Preschool Wheeze: Inflammation/Infection Guided Management

Condition:   Asthma
Interventions:   Drug: Beclometasone;   Drug: Co-amoxiclav;   Drug: Azithromycin
Sponsors:   Imperial College London;   National Institute for Health Research, United Kingdom
Completed

Thu, 06 Aug 2015 12:00:00 EDT

Eosinophil-guided Reduction of Inhaled Corticosteroids

Conditions:   COPD;   Inhaled Corticosteroid;   Azithromycin;   COPD Exacerbation;   Pneumonia
Interventions:   Drug: Azithromycin;   Drug: ICS
Sponsor:   Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Recruiting

Wed, 22 Jul 2020 12:00:00 EDT

Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease

Conditions:   Coronary Heart Disease;   Chlamydophila Pneumoniae Infections
Interventions:   Drug: Doxycycline Capsule;   Drug: Azithromycin Capsule;   Drug: Rifabutin Oral Capsule;   Drug: Placebo oral capsule;   Drug: Placebo Oral Tablet
Sponsors:   Cadrock Pty. Ltd.;   Centre for Digestive Diseases, Australia
Terminated

Tue, 07 Aug 2018 12:00:00 EDT

Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates

Conditions:   Bacteria Infection;   Respiratory Tract Infections
Intervention:   Drug: Azithromycin
Sponsor:   University of Alabama at Birmingham
Terminated

Wed, 23 Jan 2008 12:00:00 EST

Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Conditions:   Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture);   Rupture of Membranes; Premature;   Rupture of Membranes; Premature, Affecting Fetus;   Preterm Birth;   Preterm PROM (Pregnancy);   Preterm Labor
Intervention:   Drug: Antibiotics, oral Azithromycin and oral Amoxicillin
Sponsor:   Woman's
Recruiting

Wed, 07 Aug 2019 12:00:00 EDT

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

Condition:   Pneumonia
Interventions:   Drug: azithromycin sustained release;   Other: placebo;   Drug: levofloxacin
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS

Conditions:   Toxoplasmosis, Cerebral;   HIV Infections
Interventions:   Drug: Azithromycin;   Drug: Pyrimethamine;   Drug: Leucovorin calcium
Sponsors:   Pfizer;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced

Conditions:   Urethritis;   Cervicitis;   Genital Mycoplasma Infection;   Chlamydia Trachomatis
Interventions:   Drug: Azithromycin;   Drug: Doxycycline;   Drug: lymecycline
Sponsors:   Ostergotland County Council, Sweden;   Statens Serum Institut
Unknown status

Fri, 10 Aug 2012 12:00:00 EDT

An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia

Condition:   Pneumonia
Interventions:   Drug: cefuroxime plus erythromycin;   Drug: azithromycin (Zithromax);   Drug: cefuroxime
Sponsor:   Pfizer
Completed

Tue, 01 Apr 2008 12:00:00 EDT

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults

Condition:   Maxillary Sinusitis
Interventions:   Drug: azithromycin SR (Zithromax; compound: CP-62,993);   Other: placebo;   Drug: levofloxacin
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis

Condition:   Bronchitis, Chronic
Interventions:   Other: placebo;   Drug: azithromycin SR (Zithromax; compound: CP-62,993);   Drug: levofloxacin
Sponsor:   Pfizer
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Transplacental Transfer of Drugs Used in Pregnant Women

Condition:   Pregnancy
Interventions:   Drug: paracetamol;   Drug: Erythromycin;   Drug: Azithromycin
Sponsor:   University Hospital, Gasthuisberg
Completed

Mon, 07 Dec 2015 12:00:00 EST

Intrapulmonary Pharmacokinetics of Antibiotics

Condition:   Healthy
Interventions:   Drug: Telithromycin;   Drug: azithromycin;   Procedure: bronchoalveolar lavage
Sponsors:   University of Illinois at Chicago;   Sanofi
Terminated

Tue, 18 Apr 2006 12:00:00 EDT

Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT

Condition:   COVID 19
Interventions:   Drug: Hydroxychloroquine;   Drug: Oseltamivir;   Drug: Azithromycin
Sponsor:   Shehnoor Azhar
Recruiting

Wed, 08 Apr 2020 12:00:00 EDT

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Condition:   Mycobacterium Infections, Nontuberculous
Interventions:   Drug: ALIS;   Drug: Azithromycin;   Drug: Ethambutol;   Drug: ELC (matching placebo for ALIS)
Sponsor:   Insmed Incorporated
Recruiting

Mon, 21 Dec 2020 12:00:00 EST

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

Conditions:   Pregnancy;   Malaria in Pregnancy;   Malaria
Interventions:   Drug: dihydroartemisinin-piperaquine;   Drug: sulphadoxine-pyrimethamine;   Drug: dihydroartemisinin-piperaquine plus azithromycin
Sponsors:   Liverpool School of Tropical Medicine;   University of Malawi College of Medicine;   Kenya Medical Research Institute;   Malawi-Liverpool-Wellcome Trust Clinical Research Programme;   National Institute for Medical Research, Tanzania;   Kilimanjaro Christian Medical Centre, Tanzania;   University of Copenhagen;   Centers for Disease Control and Prevention;   London School of Hygiene and Tropical Medicine;   University College, London;   Tampere University;   University of Bergen;   University of Massachusetts, Worcester;   University of Toronto;   University of Melbourne;   PATH;   Foundation for Innovative New Diagnostics, Switzerland
Completed

Wed, 05 Jul 2017 12:00:00 EDT

Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides

Condition:   Inflammation
Interventions:   Other: Cantharidin;   Drug: Azithromycin;   Drug: Placebo
Sponsor:   GlaxoSmithKline
Completed

Fri, 04 Dec 2009 12:00:00 EST

TELI COM - Telithromycin in Children With Otitis Media

Conditions:   Otitis Media, Suppurative;   Otitis Media, Purulent
Interventions:   Drug: Telithromycin;   Drug: Azithromycin
Sponsor:   Sanofi
Terminated

Mon, 17 Apr 2006 12:00:00 EDT

Scrub Typhus Antibiotic Resistance Trial

Condition:   Scrub Typhus
Interventions:   Drug: Doxycycline 7 days;   Drug: Doxycycline 3 days;   Drug: Azithromycin 3 days
Sponsors:   University of Oxford;   Shoklo Malaria Research Unit;   Chiangrai Prachanukroh Hospital
Recruiting

Fri, 17 Mar 2017 12:00:00 EDT

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

Condition:   Covid19
Intervention:   Drug: Sofosbuvir plus Ledipasvir
Sponsor:   Almaza Military Fever Hospital
Completed

Fri, 28 Aug 2020 12:00:00 EDT

Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)

Condition:   Asthma
Interventions:   Drug: Budesonide + Salmeterol + Azithromycin;   Drug: Budesonide + Salmeterol + Montelukast;   Drug: Budesonide + Salmeterol + Placebo
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Terminated

Thu, 10 May 2007 12:00:00 EDT

A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)

Condition:   Chronic Bronchitis
Interventions:   Other: Moxifloxacin Placebo;   Drug: Moxifloxacin;   Other: Azithromycin SR Placebo;   Drug: Azithromycin SR
Sponsor:   Pfizer
Completed

Wed, 16 Nov 2005 12:00:00 EST

VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)

Conditions:   SARS-CoV-2;   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Drug: Placebo oral tablet
Sponsors:   Salomeh Keyhani MD;   San Francisco VA Health Care System
Suspended

Mon, 27 Apr 2020 12:00:00 EDT

Trachoma Amelioration in Northern Amhara (TANA)

Conditions:   Trachoma;   Chlamydia
Intervention:   Drug: Mass treatment with oral azithromycin to an entire community
Sponsor:   University of California, San Francisco
Completed

Tue, 09 May 2006 12:00:00 EDT

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period

Condition:   Blepharitis
Interventions:   Drug: Azithromycin ophthalmic solution, 1%;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 05 May 2009 12:00:00 EDT

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)

Condition:   Blepharitis
Interventions:   Drug: Azithromycin ophthalmic solution, 1%;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 07 May 2009 12:00:00 EDT

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

Conditions:   Pulmonary Sarcoidosis;   Lung Function
Intervention:   Drug: levaquin; ethambutol; rifampin and azithromycin.
Sponsor:   Vanderbilt University
Completed

Fri, 23 Jul 2010 12:00:00 EDT

Effectiveness of Hydroxychloroquine in Covid-19 Patients

Condition:   COVID19
Interventions:   Drug: Hydroxychloroquine 200 Mg Oral Tablet;   Drug: Azithromycin 500Mg Oral Tablet;   Dietary Supplement: Glucose tablets
Sponsors:   Prof. Dr. Umar Farooq;   Ayub Medical College, Abbottabad
Not yet recruiting

Tue, 31 Mar 2020 12:00:00 EDT

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Conditions:   Mycobacterium Avium-intracellulare Infection;   HIV Infections
Intervention:   Drug: Azithromycin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients

Condition:   IMMUNOTHERAPY
Interventions:   Biological: Convalescent plasma;   Drug: Hydroxychloroquin with Azithromycin
Sponsor:   Alkarkh Health Directorate-Baghdad
Completed

Mon, 22 Jun 2020 12:00:00 EDT

The Optimization of Mycoplasm Pneumonia Antibiotic Therapy

Condition:   Mycoplasma Pneumonia
Interventions:   Drug: Moxifloxacin;   Drug: Cephalosporins and azithromycin
Sponsor:   Capital Medical University
Completed

Tue, 14 Dec 2010 12:00:00 EST

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

Conditions:   Obesity;   Induction of Labor Affected Fetus / Newborn
Interventions:   Drug: Cefazolin;   Drug: Placebo;   Drug: Azithromycin
Sponsor:   University of Oklahoma
Completed

Fri, 11 Jan 2019 12:00:00 EST

Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

Condition:   Blepharitis
Interventions:   Drug: Azithromycin;   Drug: Povidone
Sponsors:   Laboratoires Thea;   Keyrus Biopharma;   VEEDA
Completed

Thu, 18 Mar 2010 12:00:00 EDT

A Study of Combination Therapies to Treat COVID-19 Infection

Conditions:   COVID;   COVID-19;   Corona Virus Infection;   Coronavirus Infection;   Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere;   Coronavirus-19;   SARS-CoV 2;   SARS Pneumonia
Interventions:   Drug: hydroxychloroquine;   Drug: Azithromycin;   Drug: Ritonavir;   Drug: Lopinavir
Sponsors:   ProgenaBiome;   Big Corona Ltd.
Withdrawn

Tue, 07 Jul 2020 12:00:00 EDT

Antibiotic Treatment of Recurrent Episodes of Asthma in Children

Condition:   Childhood Asthma With Acute Exacerbation
Interventions:   Drug: Azithromycin;   Other: Placebo mixture
Sponsor:   Copenhagen Studies on Asthma in Childhood
Active, not recruiting

Wed, 03 Nov 2010 12:00:00 EDT

Empiric Therapy of Mucopurulent Cervicitis (MPC)

Conditions:   Vaginitis Bacterial;   Cervicitis
Interventions:   Other: Placebo;   Drug: Azithromycin;   Drug: Cefixime
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Terminated

Fri, 19 Feb 2010 12:00:00 EST

Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease

Conditions:   Asthma;   Chronic Obstructive Pulmonary Disease
Intervention:   Drug: azithromycin
Sponsor:   Johns Hopkins University
Terminated

Fri, 16 Sep 2005 12:00:00 EDT

"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"

Condition:   Cervical Inflammation and Human Papilloma Virus Performance
Intervention:   Drug: Tab cefixime,Tab Azithromycin
Sponsor:   Tata Memorial Hospital
Unknown status

Tue, 12 Jul 2016 12:00:00 EDT

A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh

Conditions:   Ivermectin;   Hydroxychloroquine;   COVID19
Interventions:   Drug: Ivermectin + Doxycycline;   Drug: Hydroxychloroquine + Azithromycin
Sponsor:   Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar
Completed

Tue, 16 Jun 2020 12:00:00 EDT

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Conditions:   Covid19;   SARS (Severe Acute Respiratory Syndrome)
Interventions:   Drug: Hydroxychloroquine;   Dietary Supplement: Vitamins and Minerals;   Drug: Azithromycin
Sponsor:   International Brain Research Foundation
Not yet recruiting

Mon, 19 Oct 2020 12:00:00 EDT

Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections

Condition:   Upper Respiratory Tract Infections
Intervention:  
Sponsor:   Pfizer
Completed

Thu, 22 Jan 2009 12:00:00 EST

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Condition:   Mycobacterium Infections, Nontuberculous
Interventions:   Drug: ALIS;   Drug: Azithromycin;   Drug: Ethambutol;   Drug: ELC
Sponsor:   Insmed Incorporated
Recruiting

Mon, 21 Dec 2020 12:00:00 EST

Anti Infective Agents Impact in COVID-19 Pneumonia

Conditions:   COVID;   Pneumonia, Viral
Intervention:   Drug: favorable outcome
Sponsor:   Centre d'Investigation Clinique et Technologique 805
Completed

Wed, 01 Jul 2020 12:00:00 EDT

Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

Conditions:   COVID 19;   Patients Hospitalized
Interventions:   Drug: HCQ;   Drug: Azithromycin;   Drug: Doxycycline;   Dietary Supplement: Zinc
Sponsors:   Abderrahmane Mami Hospital;   Eshmoun Clinical Research Centre;   Datametrix
Withdrawn

Thu, 27 Aug 2020 12:00:00 EDT

Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis

Condition:   Sinusitis
Interventions:   Drug: Doxycycline;   Drug: Azithromycin;   Drug: Augmentin
Sponsor:   University of North Carolina, Chapel Hill
Completed

Fri, 05 Apr 2013 12:00:00 EDT

Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

Conditions:   Respiratory Tract Infections;   Bronchiolitis Obliterans;   Cryptogenic Organizing Pneumonia;   Lung Diseases, Interstitial
Interventions:   Drug: Prednisone;   Drug: Azithromycin;   Drug: Montelukast;   Drug: Symbicort
Sponsors:   Maisonneuve-Rosemont Hospital;   The Canadian Blood and Marrow Transplant Group
Terminated

Mon, 12 Sep 2011 12:00:00 EDT

Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis

Condition:   Cirrhosis
Interventions:   Drug: Imipenem;   Drug: Vancomycin;   Drug: azithromycin;   Drug: Cefotaxime;   Drug: Amoxicillin
Sponsor:   University of Roma La Sapienza
Unknown status

Thu, 28 Mar 2013 12:00:00 EDT

Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients

Conditions:   COVID;   Pulmonary Infection;   Sars-CoV2
Interventions:   Drug: Oseltamivir;   Drug: Azithromycin;   Biological: Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Indonesia University
Recruiting

Tue, 07 Jul 2020 12:00:00 EDT

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Condition:   Pneumonia
Interventions:   Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Ceftriaxone; Azithromycin; Amoxicilline/clavulanate; Clarithromycin
Sponsor:   Bayer
Completed

Thu, 17 Jul 2008 12:00:00 EDT

Chloroquine Alone or in Combination for Malaria in Children in Malawi

Condition:   Plasmodium Falciparum Infection
Interventions:   Drug: Atovaquone-proguanil;   Drug: Artesunate;   Drug: Azithromycin;   Drug: Chloroquine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Mon, 25 Sep 2006 12:00:00 EDT

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Condition:   COVID-19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsor:   LCMC Health
Active, not recruiting

Tue, 14 Apr 2020 12:00:00 EDT

Efficacy of Oral Probiotic and Antibiotic Administration in Patients With Chronic Periodontitis

Condition:   Chronic Periodontitis
Interventions:   Dietary Supplement: Lactobacillus rhamnosus SP1;   Drug: Azithromycin;   Other: Talc powder;   Procedure: Periodontal treatment Scaling and root planning
Sponsor:   University of Chile
Unknown status

Thu, 21 Jul 2016 12:00:00 EDT

Multiple Treatments for Ebola Virus Disease (EVD)

Condition:   Ebola Virus Disease
Interventions:   Drug: Azithromycin;   Drug: Sunitinib and Erlotinib;   Drug: Atorvastatin and Irbesartan;   Other: IV fluids and laboratory testing
Sponsors:   Clinical Research Management, Inc.;   Bill and Melinda Gates Foundation;   Duke University;   University of Sierra Leone;   Syneos Health;   University of North Carolina
Unknown status

Thu, 05 Mar 2015 12:00:00 EST

Study on Periodontal Treatment in Diabetic Patients

Conditions:   Diabetes;   Gingivitis;   Periodontitis
Interventions:   Drug: Scaling and root planing plus placebo;   Drug: Scaling and root planing plus azythromycin;   Drug: Prophylaxis plus azythromycin
Sponsors:   Universidad de Antioquia;   Colgate Palmolive
Completed

Thu, 06 Jan 2011 12:00:00 EST

Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne

Condition:   Acne
Intervention:   Drug: Levamisole
Sponsor:   Ahvaz Jundishapur University of Medical Sciences
Completed

Thu, 05 May 2011 12:00:00 EDT

Treatment of Chronic Cryptosporidiosis in AIDS Patients

Conditions:   Cryptosporidiosis;   HIV Infections
Interventions:   Drug: Interleukin-12;   Drug: Paromomycin sulfate;   Drug: Azithromycin
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Genetics Institute
Terminated

Fri, 31 Aug 2001 12:00:00 EDT

International ALLIANCE Study of Therapies to Prevent Progression of COVID-19

Condition:   COVID19
Interventions:   Dietary Supplement: Vitamin C;   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Dietary Supplement: Zinc Citrate;   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin B12
Sponsor:   National Institute of Integrative Medicine, Australia
Recruiting

Wed, 20 May 2020 12:00:00 EDT

Typhoid Fever: Combined vs. Single Antibiotic Therapy

Condition:   Typhoid Fever
Interventions:   Drug: ceftriaxone;   Drug: ceftriaxone and azithromycin;   Drug: azithromycin;   Drug: azithromycin and cefixime
Sponsor:   Sheba Medical Center
Unknown status

Fri, 22 Aug 2014 12:00:00 EDT

Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19

Condition:   Acute Respiratory Distress Syndrome
Interventions:   Drug: Wharton's jelly derived Mesenchymal stem cells.;   Drug: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)
Sponsors:   BioXcellerator;   Clinical Somer
Recruiting

Fri, 15 May 2020 12:00:00 EDT

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Chronic Obstructive Pulmonary Disease (COPD).
Interventions:   Drug: Moxifloxacin;   Drug: Azithromycin;   Drug: Doxycycline;   Drug: Placebo
Sponsors:   University College, London;   Royal Free Hampstead NHS Trust;   University of Cambridge;   National Institute for Health Research, United Kingdom
Unknown status

Wed, 20 Jul 2011 12:00:00 EDT

Effect of Antibiotics on Gut Microbiome and Plasma Metabolome

Condition:   Microbial Colonization
Interventions:   Drug: Amoxicillin;   Drug: Azithromycin;   Drug: Vancomycin
Sponsors:   Finnish Institute for Health and Welfare;   University of California, San Diego;   Brigham and Women's Hospital
Completed

Wed, 06 Sep 2017 12:00:00 EDT

Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection

Conditions:   Periodontal Disease;   Chronic Periodontitis
Interventions:   Procedure: Scaling and root planing;   Procedure: Full mouth disinfection;   Drug: Chlorhexidine gel and gluconate;   Drug: Chlorhexidine gluconate solution;   Drug: Azithromycin
Sponsors:   Centro Universitario de Lavras;   Federal University of Minas Gerais
Completed

Tue, 29 Apr 2014 12:00:00 EDT

Treatment of Bacterial Vaginosis

Condition:   Bacterial Vaginosis
Intervention:   Drug: metronidazole and azithromycin
Sponsors:   University of Alabama at Birmingham;   Pfizer
Completed

Thu, 11 May 2006 12:00:00 EDT

Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old

Condition:   Moderate Acute Malnutrition
Interventions:   Drug: Azythromycin;   Dietary Supplement: Inuline and fructo-oligosaccharides;   Drug: Albendazole;   Dietary Supplement: Fortified blend flour
Sponsors:   Institut Pasteur;   Action Contre la Faim;   Centre de Recherches Médicales et Sanitaires CERMES Niger;   Institut Pasteur de Madagascar;   Institut Pasteur de Bangui;   Institut Pasteur de Dakar
Completed

Thu, 22 Mar 2018 12:00:00 EDT

Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation

Condition:   Lyme Disease
Intervention:   Drug: Application of SHB001
Sponsors:   University of Zurich;   Ixodes GmbH;   Appletree AG
Completed

Wed, 17 Nov 2010 12:00:00 EST

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

Conditions:   Fatty Liver;   Liver Dysfunction;   Insulin Resistance
Intervention:   Drug: H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin)
Sponsor:   Tehran University of Medical Sciences
Completed

Wed, 12 Jun 2013 12:00:00 EDT

Bacteriotherapy in the Treatment of COVID-19

Conditions:   COVID;   Pneumonia;   Diarrhea
Interventions:   Dietary Supplement: SivoMixx (200 billion);   Drug: Azithromycin;   Drug: hydroxychloroquine
Sponsor:   University of Roma La Sapienza
Active, not recruiting

Wed, 29 Apr 2020 12:00:00 EDT

Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)

Conditions:   Normal Physiology;   Healthy
Interventions:   Drug: Amoxicillin;   Drug: Azithromycin;   Other: Control
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Mon, 14 Mar 2016 12:00:00 EDT

Treatment of Pediculosis (Head Lice) in Senegal

Condition:   Pediculoses
Intervention:   Drug: Ivermectin Oral Product
Sponsor:   Institut de Recherche pour le Developpement
Completed

Fri, 06 Jul 2018 12:00:00 EDT

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

Condition:   COVID-19
Interventions:   Drug: Tocilizumab;   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsors:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Instituto de Salud Carlos III
Recruiting

Thu, 02 Apr 2020 12:00:00 EDT

Effects of Macrolides on Asthma Control

Condition:   Asthma
Interventions:   Drug: Azithromycin;   Drug: Placebo
Sponsors:   Euan J Cameron;   University of Glasgow;   NHS Greater Glasgow and Clyde
Completed

Fri, 27 Feb 2009 12:00:00 EST

Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients

Condition:   COVID-19
Intervention:   Drug: HCQ & AZ
Sponsor:   King Hussein Cancer Center
Not yet recruiting

Tue, 21 Apr 2020 12:00:00 EDT

Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19

Condition:   COVID-19
Intervention:  
Sponsor:   Institut Mutualiste Montsouris
Completed

Tue, 30 Jun 2020 12:00:00 EDT

Reducing Cost of Azythromycin by Transferring From IV to Oral Therapy

Condition:   Pneumonia
Intervention:   Behavioral: education
Sponsor:   HaEmek Medical Center, Israel
Withdrawn

Wed, 05 Dec 2012 12:00:00 EST

Outpatient Registry Trial of Respiratory Tract Infections in Adults

Conditions:   Pneumonia, Bacterial;   Bronchitis, Chronic
Interventions:   Drug: azithromycin;   Drug: telithromycin;   Drug: Clarythromycin
Sponsors:   CPL Associates;   Sanofi
Withdrawn

Fri, 28 Oct 2005 12:00:00 EDT

A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

Conditions:   Bacterial Infections;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions:   Drug: Azithromycin;   Drug: Atovaquone;   Drug: Sulfamethoxazole-Trimethoprim
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Pfizer;   Glaxo Wellcome;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy

Condition:   Pregnancy
Interventions:   Drug: ciprofloxacin;   Drug: azithromycin;   Drug: gentamicin
Sponsors:   University of Wisconsin, Madison;   Food and Drug Administration (FDA)
Completed

Wed, 21 Sep 2005 12:00:00 EDT

Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?

Condition:   Pneumonia
Intervention:  
Sponsor:   HaEmek Medical Center, Israel
Completed

Wed, 14 Mar 2012 12:00:00 EDT

Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)

Condition:   Patients With COVID19
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin
Sponsors:   Abderrahmane Mami Hospital;   Eshmoun Clinical Research Centre;   Dacima Consulting
Withdrawn

Fri, 17 Apr 2020 12:00:00 EDT

A Study of Quintuple Therapy to Treat COVID-19 Infection

Conditions:   COVID-19;   Corona Virus Infection;   Coronavirus-19;   Sars-CoV2
Interventions:   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Dietary Supplement: Vitamin C;   Dietary Supplement: Vitamin D;   Dietary Supplement: Zinc
Sponsors:   ProgenaBiome;   DSCS CRO
Recruiting

Mon, 06 Apr 2020 12:00:00 EDT

A P3 Comparator Trial in Community Acquired Bacterial Pneumonia

Condition:   Community Acquired Pneumonia
Interventions:   Drug: Dalbavancin;   Drug: Linezolid;   Drug: Linezolid Placebo;   Drug: Azithromycin
Sponsor:   Durata Therapeutics Inc., an affiliate of Allergan plc
Withdrawn

Tue, 21 Oct 2014 12:00:00 EDT

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

Condition:   Sinusitis
Interventions:   Drug: Zithromax™ (azithromycin) 500mg tablets;   Procedure: Endoscopic Sinus Surgery;   Procedure: Blood sampling for hematology;   Procedure: Blood sampling for plasma chemistry profile;   Procedure: Serum pregnancy test (for women of child-bearing potential)
Sponsor:   Pfizer
Completed

Tue, 04 Oct 2005 12:00:00 EDT

Chlamydia Trachomatis Immunology and Vaccinology Study

Condition:   Chlamydia
Interventions:   Drug: ceftriaxone;   Drug: Azithromycin
Sponsors:   Harold Wiesenfeld;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Mon, 28 Jun 2010 12:00:00 EDT

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome

Condition:   COVID
Interventions:   Drug: Azithromycin;   Drug: Hydroxychloroquine;   Drug: Lopinavir 200Mg/Ritonavir 50Mg Tab
Sponsor:   Groupe Hospitalier Paris Saint Joseph
Withdrawn

Tue, 28 Apr 2020 12:00:00 EDT

Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19

Condition:   COVID-19
Interventions:   Drug: Doxycycline Tablets;   Drug: Rivaroxaban 15Mg Tab;   Combination Product: Hydroxychloroquine and Azithromycin
Sponsor:   Yaounde Central Hospital
Recruiting

Wed, 20 Jan 2021 12:00:00 EST

Ivermectin for Severe COVID-19 Management

Condition:   COVID-19
Intervention:   Drug: Ivermectin
Sponsors:   Afyonkarahisar Health Sciences University;   NeuTec Pharma
Completed

Fri, 27 Nov 2020 12:00:00 EST

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

Condition:   Respiratory Syncytial Virus Infections
Interventions:   Drug: AZM Group;   Other: Control Group
Sponsor:   University of Alabama at Birmingham
Not yet recruiting

Mon, 30 Aug 2021 12:00:00 EDT

Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers

Conditions:   Neisseria Gonorrhoeae Infection;   Chlamydia Trachomatis;   HIV
Interventions:   Drug: Monthly antibiotic;   Drug: Monthly placebo
Sponsors:   CHU de Quebec-Universite Laval;   Maisonneuve-Rosemont Hospital;   Centre de recherche du Centre hospitalier universitaire de Sherbrooke;   Ministry of Health, Benin
Completed

Wed, 06 Apr 2011 12:00:00 EDT

Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

Conditions:   Acute Watery Diarrhea;   Dysentery/Febrile Diarrhea
Interventions:   Drug: Single dose rifaximin 1650 mg;   Drug: Single dose azithromycin 500 mg;   Drug: Single dose levofloxacin 500 mg;   Drug: Single dose azithromycin 1000 mg plus loperamide;   Drug: Single dose azithromycin 1000 mg plus placebo
Sponsors:   Uniformed Services University of the Health Sciences;   Navy Bureau of Medicine and Surgery;   Ministry of Defence, United Kingdom;   Naval Medical Research Center;   Naval Medical Research Unit- 3;   United States Army Medical Unit - Kenya;   United States Naval Medical Center, Portsmouth;   Naval Medical Research Unit- 6
Terminated

Wed, 13 Jun 2012 12:00:00 EDT

Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS

Condition:   Pandas
Interventions:   Drug: Sertraline+Antibiotic (penicillin/azithromycin);   Drug: Sertraline+placebo;   Biological: IVIG
Sponsors:   CNS Onlus;   University of Florence
Unknown status

Wed, 16 Jan 2013 12:00:00 EST

Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections

Conditions:   Infection;   Obstetric Labor Complications;   Endometritis;   Cesarean Delivery Affecting Fetus;   Wounds Injuries
Intervention:   Procedure: Vaginal Preparation
Sponsor:   Womack Army Medical Center
Recruiting

Fri, 15 Nov 2019 12:00:00 EST

Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

Condition:   Cystic Fibrosis
Interventions:   Drug: Ethambutol;   Drug: Rifampin;   Drug: Azithromycin;   Drug: Pancrelipase
Sponsors:   University of Colorado, Denver;   Cystic Fibrosis Foundation;   Colorado Clinical & Translational Sciences Institute
Completed

Thu, 26 Feb 2015 12:00:00 EST

Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis

Condition:   Sarcoidosis; Antimycobacterial Therapy
Interventions:   Drug: Levofloxacin;   Drug: Ethambutol;   Drug: Azithromycin;   Drug: Rifampin;   Drug: Placebo
Sponsors:   Vanderbilt University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Tue, 31 Dec 2013 12:00:00 EST

A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions

Condition:   First Trimester Abortion
Interventions:   Drug: Azithromycin;   Drug: Doxycycline;   Drug: Metronidazole;   Drug: Placebo
Sponsors:   Medstar Health Research Institute;   Society of Family Planning
Completed

Fri, 29 Apr 2016 12:00:00 EDT

Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora

Conditions:   COVID;   SARS-CoV 2;   Pneumonia, Viral;   Coronavirus Infection
Interventions:   Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care;   Dietary Supplement: SivoMixx (200 billion);   Drug: Azithromycin;   Drug: hydroxychloroquine
Sponsor:   Roberto Poscia MD, PhD
Recruiting

Tue, 28 Apr 2020 12:00:00 EDT

Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia

Conditions:   Low Birthweight;   Preterm Birth;   Maternal; Malnutrition, Affecting Fetus;   Sexually Transmitted Diseases;   Urinary Tract Infections;   Pregnancy and Infectious Disease
Interventions:   Drug: Azithromycin 500 mg;   Dietary Supplement: Multiple Micronutrient or Fortified Balanced Energy Protein Supplement;   Drug: Placebo oral tablet 500 mg;   Other: Enhanced Infection Management Package (EIMP)
Sponsors:   Brigham and Women's Hospital;   Addis Continental Institute of Public Health;   Johns Hopkins Bloomberg School of Public Health;   Boston Children's Hospital;   Beth Israel Deaconess Medical Center;   Harvard School of Public Health;   Amhara Public Health Institute;   Jhpiego
Withdrawn

Wed, 20 Nov 2019 12:00:00 EST

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

Condition:   Bronchiectasis
Interventions:   Drug: inhaled corticosteroid therapy;   Drug: macrolide therapy
Sponsors:   Oregon Health and Science University;   Patient-Centered Outcomes Research Institute;   University of Alabama at Birmingham;   National Jewish Health;   COPD Foundation
Completed

Mon, 21 Mar 2016 12:00:00 EDT

Protein Plus: Improving Infant Growth Through Diet and Enteric Health

Conditions:   Stunting;   Malnutrition; Protein;   Enteric Pathogens;   Campylobacter Infections
Interventions:   Drug: Azithromycin Oral Product;   Drug: Placebos;   Dietary Supplement: Protein Supplement;   Dietary Supplement: Isocaloric Supplement;   Dietary Supplement: Egg;   Behavioral: Nutrition Education
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   International Centre for Diarrhoeal Disease Research, Bangladesh;   Bill and Melinda Gates Foundation
Active, not recruiting

Tue, 25 Sep 2018 12:00:00 EDT

Chronic Bronchiolitis or Resistant Asthma?

Condition:   Asthma
Intervention:   Drug: Erythromycin, Azithromycin , Clarithromycin
Sponsor:   Baqiyatallah Medical Sciences University
Completed

Thu, 24 Aug 2006 12:00:00 EDT

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients

Condition:   HIV Infection
Intervention:   Other: Discontinuation of prophylactic drugs i.e. co-trimoxazole, dapsone, fluconazole, itraconazole, azithromycin
Sponsor:   Chiang Mai University
Completed

Tue, 12 Jul 2011 12:00:00 EDT

A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.

Conditions:   Bronchitis;   Chronic Bronchitis
Intervention:   Drug: levofloxacin, azithromycin, amoxicillin/clavulanate
Sponsors:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;   PriCara, Unit of Ortho-McNeil, Inc.
Completed

Wed, 07 Aug 2002 12:00:00 EDT

A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

Conditions:   Pneumonia, Viral;   Respiratory Failure
Interventions:   Drug: Mefloquine;   Drug: Hydroxychloroquine;   Combination Product: Mefloquine + azithromycin + / - tocilizumab;   Combination Product: Hydroxychloroquine + azithromycin + / - tocilizumab
Sponsor:   Burnasyan Federal Medical Biophysical Center
Completed

Wed, 15 Apr 2020 12:00:00 EDT

Sanitation, Water, and Instruction in Face-washing for Trachoma I/II

Condition:   Trachoma
Interventions:   Behavioral: Water, sanitation, and hygiene (WASH) intervention;   Behavioral: Standard of care WASH intervention;   Drug: Azithromycin;   Drug: Tetracycline;   Other: Control
Sponsors:   University of California, San Francisco;   The Carter Center;   Amhara Public Health Institute;   Emory University;   National Eye Institute (NEI)
Recruiting

Thu, 28 Apr 2016 12:00:00 EDT

Early Life Interventions for Childhood Growth and Development In Tanzania

Conditions:   Malnutrition;   Stunting;   Cognitive Development;   Enteric Pathogens
Interventions:   Drug: Azithromycin Oral Liquid Product;   Drug: Nitazoxanide Oral Suspension;   Dietary Supplement: Nicotinamide;   Drug: Placebos
Sponsors:   Haydom Lutheran Hospital;   University of Virginia;   Bill and Melinda Gates Foundation
Completed

Thu, 31 Aug 2017 12:00:00 EDT

Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19

Conditions:   Sars-CoV2;   COVID-19
Interventions:   Drug: Favipiravir (3200 mg + 1200 mg);   Drug: Favipiravir (3600 mg + 1600 mg);   Drug: Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine;   Drug: Favipiravir (3200 mg + 1200 mg) combined with Azithromycin;   Drug: Hydroxychloroquine;   Drug: Hydroxychloroquine combined with Azithromycin
Sponsors:   Ministry of Health, Turkey;   Hacettepe University, Faculty of Medicine;   Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization;   Umraniye Education and Research Hospital;   SB Istanbul Education and Research Hospital;   Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey;   Tepecik Training and Research Hospital;   Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine;   Ankara University;   Ankara City Hospital Bilkent;   Ankara Training and Research Hospital;   Ege University Hospital (Application and Research Center);   Kocaeli Derince Education and Research Hospital;   Istanbul University;   Kayseri City Hospital
Active, not recruiting

Tue, 02 Jun 2020 12:00:00 EDT

EAT-DUTA AndroCoV Trial

Condition:   Covid19
Interventions:   Drug: Dutasteride 0.5 mg;   Drug: Azithromycin;   Drug: Nitazoxanide;   Drug: Placebo
Sponsor:   Corpometria Institute
Completed

Thu, 28 Jan 2021 12:00:00 EST

Trial of Antimycobacterial Therapy in Sarcoidosis

Condition:   Sarcoidosis
Interventions:   Drug: Antibiotic Regimen;   Drug: Placebo Regimen
Sponsor:   Vanderbilt University
Completed

Wed, 24 Feb 2010 12:00:00 EST

A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Conditions:   Mycobacterium Avium-intracellulare Infection;   HIV Infections
Interventions:   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Azithromycin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract Infection

Condition:   Respiratory Tract Infections
Interventions:   Drug: Azithromycin;   Drug: non-macrolides antibiotics;   Diagnostic Test: Mycoplasma detection;   Other: Data collection
Sponsors:   Shanghai Children's Medical Center;   Beijing Children's Hospital;   Tianjin Children's Hospital;   Xi 'an children's hospital;   Shenzhen Children's Hospital;   Third Affiliated Hospital of Zhengzhou University;   Shanghai Children's Hospital;   Children's Hospital of Chongqing Medical University;   Wuhan Children's Hospital;   The First Affiliated Hospital of Guangzhou Medical University
Unknown status

Tue, 15 Oct 2019 12:00:00 EDT

Fluoroquinolone Associated Disability

Conditions:   Bronchitis;   Sinusitis;   Urinary Tract Infections
Interventions:   Drug: Fluoroquinolone (FQ);   Drug: Azithromycin (AZ);   Drug: Sulfamethoxazole/Trimethoprim (ST) Fixed Dose Combination
Sponsor:   Janssen Research & Development, LLC
Completed

Thu, 24 May 2018 12:00:00 EDT

Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management

Condition:   COVID 19
Intervention:   Drug: Ivermectin (IVM)
Sponsor:   University of Baghdad
Completed

Mon, 13 Apr 2020 12:00:00 EDT

Treatment for COVID-19 in High-Risk Adult Outpatients

Conditions:   COVID-19;   SARS-CoV-2
Interventions:   Drug: Ascorbic Acid;   Drug: Hydroxychloroquine Sulfate;   Drug: Azithromycin;   Drug: Folic Acid;   Drug: Lopinavir 200 MG / Ritonavir 50 MG [Kaletra]
Sponsors:   University of Washington;   Bill and Melinda Gates Foundation
Active, not recruiting

Tue, 21 Apr 2020 12:00:00 EDT

Hypertonic Saline for MAC

Conditions:   Nontuberculous Mycobacterial Lung Disease;   Nontuberculous Mycobacterium Infection
Interventions:   Drug: Hypertonic saline;   Drug: Azithromycin;   Drug: Ethambutol;   Drug: Rifampin
Sponsors:   Oregon Health and Science University;   NTM Info & Research, Inc.;   University Health Network, Toronto;   New York University
Recruiting

Thu, 10 Jun 2021 12:00:00 EDT

Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania

Condition:   Trachoma
Intervention:   Behavioral: community surveillance and re-treatment
Sponsors:   Johns Hopkins University;   International Trachoma Initiative
Completed

Tue, 04 Jul 2006 12:00:00 EDT

Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore

Condition:   COVID-19
Interventions:   Drug: Remdesivir;   Drug: Conventional
Sponsor:   King Edward Medical University
Completed

Tue, 04 May 2021 12:00:00 EDT

Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)

Condition:   Gonococcal Infection
Interventions:   Drug: Azithromycin;   Drug: Ceftriaxone;   Drug: Ciprofloxacin;   Biological: Neisseria gonorrhoeae strain FA1090 A26;   Biological: Neisseria gonorrhoeae strain FA7527
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Mon, 03 May 2021 12:00:00 EDT

Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours

Condition:   Periodontitis
Interventions:   Procedure: FMS full-mouth scaling;   Procedure: QS quadrant scaling;   Drug: FMS chlorhexidine rinse;   Drug: FMS placebo rinse;   Drug: FMS azithromycin tablets;   Drug: FMS placebo tablets;   Drug: QS azithromycin tablets;   Drug: QS placebo tablets;   Drug: QS chlorhexidine rinse;   Drug: QS placebo rinse
Sponsors:   University of Taubate;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed

Wed, 13 Aug 2014 12:00:00 EDT

Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy Individuals

Conditions:   Quorum Sensing;   Prebiotics;   Probiotics;   Sepsis
Interventions:   Dietary Supplement: Bifidobacterium longum BB536;   Dietary Supplement: Active hexose correlated compound (AHCC);   Dietary Supplement: Bifidobacterium longum BB536 and Active hexose correlated compound (AHCC);   Dietary Supplement: Corn starch placebo capsule;   Drug: Azithromycin
Sponsor:   University of Nottingham
Completed

Tue, 14 Sep 2010 12:00:00 EDT

Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System

Conditions:   COVID19;   Corona Virus Infection;   Myocardial Injury;   Pneumonia
Intervention:   Other: BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM
Sponsor:   University of Sao Paulo General Hospital
Not yet recruiting

Mon, 20 Apr 2020 12:00:00 EDT

Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation

Condition:   Bronchiolitis Obliterans Syndrome
Interventions:   Procedure: Pulmonary function testing;   Drug: FAM Therapy
Sponsor:   Ann & Robert H Lurie Children's Hospital of Chicago
Unknown status

Tue, 07 Mar 2017 12:00:00 EST

COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy

Condition:   SARS-CoV-2
Intervention:   Drug: Methylene Blue and Photodynamic Therapy
Sponsors:   I.M. Sechenov First Moscow State Medical University;   Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS)
Completed

Tue, 22 Jun 2021 12:00:00 EDT

Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)

Conditions:   Pregnancy;   Malnutrition in Pregnancy;   Nutrition Disorders;   Stunting
Interventions:   Dietary Supplement: Ready-to-use-supplementary food;   Dietary Supplement: Corn-soy-blend;   Drug: Monthly intermittent preventive treatment of malaria during pregnancy (IPTp);   Drug: Standard intermittent preventive treatment of malaria during pregnancy (IPTp);   Other: Insecticide-treated mosquito net;   Drug: Azithromycin;   Drug: Albendazole;   Combination Product: Bacterial vaginosis testing and treatment
Sponsors:   Washington University School of Medicine;   The Children's Investment Fund Foundation
Completed

Tue, 14 Mar 2017 12:00:00 EDT

Macrolides in COPD- Bronchiectasis Overlap

Condition:   Bronchiectasis
Intervention:   Drug: Macrolides
Sponsor:   Assiut University
Not yet recruiting

Thu, 02 Jan 2020 12:00:00 EST

Incubation Time and Test of Cure of Chlamydia Trachomatis

Condition:   Chlamydia Trachomatis Infection
Intervention:  
Sponsor:   Maastricht University Medical Center
Completed

Fri, 07 Oct 2011 12:00:00 EDT

Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

Conditions:   Mycobacterium Avium-intracellulare Infection;   HIV Infections;   Pneumococcal Infections
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Convalescent Plasma Treatment in COVID-19

Condition:   Covid19
Interventions:   Biological: Convalescent Plasma (CP);   Other: Drugs and supportive care
Sponsor:   Aga Khan University
Completed

Mon, 20 Jul 2020 12:00:00 EDT

Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

Condition:   COVID-19 Pneumonia
Interventions:   Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells;   Drug: Antibiotics;   Drug: Hormones;   Drug: Anticoagulant Therapy;   Device: Оxygen therapy
Sponsors:   Institute of Cell Therapy;   Kyiv City Clinical Hospital # 4
Recruiting

Wed, 08 Jul 2020 12:00:00 EDT

Personalized Treatment Algorithms for Difficult-to-treat Asthma

Condition:   Asthma in Children
Interventions:   Drug: Cholecalciferol;   Drug: antihistamine;   Drug: Azithromycin;   Drug: emollient cream;   Drug: Fluticasone Propionate;   Drug: Asthma Controller Medication
Sponsor:   Children's Hospital Medical Center, Cincinnati
Completed

Wed, 27 Nov 2019 12:00:00 EST

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

Condition:   Human Immunodeficiency Virus
Interventions:   Drug: Raltegravir;   Drug: Fluconazole;   Drug: Azithromycin;   Drug: Albendazole;   Drug: Isoniazid;   Dietary Supplement: Ready to Use Supplementary Food
Sponsors:   Anna Griffiths, MRC;   Department for International Development, United Kingdom;   Wellcome Trust;   Medical Research Council;   PENTA Foundation
Completed

Fri, 05 Apr 2013 12:00:00 EDT

Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use

Conditions:   Snoring;   Strep Throat
Intervention:   Drug: Antibiotic
Sponsor:   University of Missouri-Columbia
Completed

Fri, 23 Mar 2012 12:00:00 EDT

Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia

Condition:   Pneumonia
Interventions:   Drug: Xiyanping injection;   Drug: wind-heat formula granules;   Drug: phlegm-heat formula granules;   Drug: Fu-xiong San;   Drug: second generation cephalosporin;   Drug: Erythromycin;   Drug: Azithromycin
Sponsors:   Liaoning University of Traditional Chinese Medicine;   Beijing University of Chinese Medicine
Unknown status

Fri, 13 Feb 2015 12:00:00 EST

Airway Microbiota Based Treatment of Asthma in Preschool Children

Condition:   Asthma in Children
Interventions:   Procedure: Microbiota and eosinophils based therapy;   Drug: Clinical guidelines based therapy
Sponsor:   Children's Hospital of Fudan University
Not yet recruiting

Wed, 26 Aug 2020 12:00:00 EDT

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Condition:   Pulmonary Disease Due to Mycobacteria (Diagnosis)
Interventions:   Drug: Amikacin;   Drug: Tigecycline;   Drug: Imipenem;   Drug: Cefoxitin;   Drug: Azithromycin;   Drug: Clarithromycin;   Drug: Clofazimine;   Drug: Ethambutol;   Drug: Linezolid;   Drug: co-trimoxazole;   Drug: Doxycycline;   Drug: Moxifloxacin;   Drug: Bedaquiline;   Drug: Rifabutin
Sponsors:   The University of Queensland;   Australian Government Department of Health and Ageing;   Children's Hospital Foundation;   Cystic Fibrosis Foundation;   Newcastle University;   Griffith University;   Erasmus Medical Center;   Monash University;   University of Copenhagen;   Hôpital Cochin;   South Australian Health and Medical Research Institute;   University of Melbourne;   James Cook University, Queensland, Australia;   Murdoch Childrens Research Institute
Recruiting

Tue, 17 Mar 2020 12:00:00 EDT

Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus

Condition:   COVID-19
Interventions:   Dietary Supplement: Natural Honey;   Other: Standard Care
Sponsor:   Misr University for Science and Technology
Recruiting

Thu, 26 Mar 2020 12:00:00 EDT

Patient Preference Trial for COVID-19 (PPT-COVID)

Condition:   Coronavirus
Intervention:  
Sponsor:   Centre Hospitalier Princesse Grace
Withdrawn

Fri, 05 Jun 2020 12:00:00 EDT

Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya

Conditions:   Malaria in Pregnancy;   Adherence, Treatment
Interventions:   Drug: Monthly intermittent preventive treatment with dihydroartemisnin-piperaquine;   Drug: Monthly intermittent preventive treatment with sulfadoxine-pyrimethamine;   Drug: Monthly intermittent preventive treatment with dihydroartemisnin-piperaquine with targeted information transfer
Sponsors:   Liverpool School of Tropical Medicine;   Kenya Medical Research Institute;   University of Malawi College of Medicine;   National Institute for Medical Research, Tanzania;   London School of Hygiene and Tropical Medicine;   University of Bergen;   Kilimanjaro Christian Medical Centre, Tanzania
Completed

Tue, 12 Nov 2019 12:00:00 EST

Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19

Condition:   COVID-19
Interventions:   Drug: PHR160 Spray;   Drug: Placebo;   Drug: Standard treatment
Sponsor:   Baqiyatallah Medical Sciences University
Recruiting

Thu, 09 Jul 2020 12:00:00 EDT

Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients

Conditions:   HIV Infections;   Cryptosporidiosis
Intervention:   Drug: IL-12
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Terminated

Thu, 03 Apr 2003 12:00:00 EST

Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD

Condition:   Bronchitis, Chronic
Intervention:   Drug: Telithromycin
Sponsor:   Sanofi
Completed

Tue, 02 Oct 2007 12:00:00 EDT

PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

Condition:   Chronic Bronchitis
Intervention:   Drug: telithromycin
Sponsor:   Sanofi
Completed

Mon, 22 Aug 2005 12:00:00 EDT

The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study

Condition:   Gonorrhoea
Intervention:   Drug: Cefixime
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Tue, 24 Sep 2013 12:00:00 EDT

Randomised Evaluation of COVID-19 Therapy

Condition:   Severe Acute Respiratory Syndrome
Interventions:   Drug: Lopinavir-Ritonavir;   Drug: Corticosteroid;   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Biological: Convalescent plasma;   Drug: Tocilizumab;   Biological: Immunoglobulin;   Drug: Synthetic neutralising antibodies;   Drug: Aspirin;   Drug: Colchicine;   Drug: Baricitinib;   Drug: Anakinra;   Drug: Dimethyl fumarate;   Drug: High Dose Corticosteroid;   Drug: Empagliflozin
Sponsors:   University of Oxford;   UK Research and Innovation;   National Institute for Health Research, United Kingdom;   Wellcome;   Bill and Melinda Gates Foundation;   Department for International Development, United Kingdom;   Health Data Research UK;   Medical Research Council Population Health Research Unit;   NIHR Clinical Trials Unit Support Funding;   NIHR Health Protection Research Unit in Emerging and Zoonotic Infections
Recruiting

Mon, 11 May 2020 12:00:00 EDT

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

Condition:   Community-acquired Bacterial Pneumonia
Interventions:   Drug: Solithromycin;   Drug: Standard of Care
Sponsors:   Melinta Therapeutics, Inc.;   Biomedical Advanced Research and Development Authority
Terminated

Mon, 16 Nov 2015 12:00:00 EST

Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients

Condition:   Covid19
Interventions:   Combination Product: Hydroxycloroquine and Azythromycine;   Combination Product: Cospherunate/Azythromycine;   Combination Product: Cospherunate/Phytomedicine/Azythromycien
Sponsor:   Institute for Research and Development of Medicinal and Food Plants of Guinea
Enrolling by invitation

Thu, 06 Aug 2020 12:00:00 EDT

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Conditions:   Mycobacterium Avium-intracellulare Infection;   HIV Infections
Interventions:   Drug: Ciprofloxacin hydrochloride;   Drug: Ethambutol hydrochloride;   Drug: Amikacin sulfate;   Drug: Azithromycin;   Drug: Rifampin;   Drug: Clofazimine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 31 Aug 2001 12:00:00 EDT

Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections

Conditions:   Influenza;   Lower Respiratory Tract Infection
Intervention:   Drug: Macrolide treatment
Sponsor:   Chinese University of Hong Kong
Completed

Wed, 30 Jan 2013 12:00:00 EST

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Conditions:   Lactating Women on Select DOI;   Breastfed Infants of Mothers on Select DOI
Interventions:   Other: Tranexamic acid (TXA);   Other: labetalol;   Other: metformin;   Other: nifedipine;   Other: clindamycin;   Other: oxycodone;   Other: azithromycin;   Other: escitalopram;   Other: sertraline;   Other: ondansetron;   Other: Ciprofloxacin;   Other: Doxycycline;   Other: Levofloxacin;   Other: Methylphenidate;   Other: Sumatriptan;   Other: Citalopram;   Other: Cyclobenzaprine;   Other: Furosemide;   Other: Gabapentin;   Other: Hydrochlorothiazide;   Other: Hydroxyurea;   Other: Rosuvastatin;   Other: Topiramate;   Other: Trazodone;   Other: Valganciclovir;   Other: Venlafaxine;   Other: Verapamil;   Other: Remdesivir;   Other: Anakinra;   Other: Tocilizumab;   Other: Fluvoxamine
Sponsors:   Duke University;   The Emmes Company, LLC;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Fri, 27 Apr 2018 12:00:00 EDT

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19

Conditions:   Covid-19;   Corona Virus Infection;   SARS-CoV 2
Interventions:   Drug: Oxytocin;   Drug: Standard of Care
Sponsors:   Azienda Ospedaliero-Universitaria di Parma;   University of Parma
Withdrawn

Wed, 13 May 2020 12:00:00 EDT

Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneumonia

Condition:   Community Acquired Pneumonia
Intervention:   Drug: Cephalosporins and Macrolide Antibiotics
Sponsor:   Beijing Children's Hospital
Recruiting

Wed, 18 May 2016 12:00:00 EDT

Timing of Antibiotic Prophylaxis for Cesarean Deliveries

Condition:   Infection
Intervention:   Drug: Antibiotic
Sponsor:   University of Florida
Completed

Tue, 09 Dec 2008 12:00:00 EST

Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis

Condition:   Non-alcoholic Fatty Liver Disease
Intervention:   Drug: H.pylori eradication
Sponsor:   Tehran University of Medical Sciences
Completed

Tue, 31 Jul 2012 12:00:00 EDT

Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease

Condition:   Non-alcoholic Fatty Liver Disease
Intervention:   Drug: H.pylori eradication
Sponsors:   Tehran University of Medical Sciences;   Kashan University of Medical Sciences
Completed

Thu, 03 Jan 2013 12:00:00 EST

An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years

Conditions:   Pneumonia, Pneumococcal;   Invasive Pneumococcal Disease;   Acute Otitis Media
Intervention:   Other: Detection of Streptococcus pneumoniae strains
Sponsor:   The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)
Completed

Thu, 09 Jul 2020 12:00:00 EDT

Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease

Condition:   Non-alcoholic Fatty Liver Disease
Intervention:   Drug: H.pylori eradication
Sponsor:   Tehran University of Medical Sciences
Completed

Tue, 23 Oct 2012 12:00:00 EDT

Reason Evaluation of Initial Treatment Failure in Patients With CAP

Condition:   Community-acquired Pneumonia
Intervention:   Drug: Moxifloxacin Hydrochloride and Sodium Chloride Injection
Sponsor:   Peking Union Medical College Hospital
Unknown status

Tue, 12 Sep 2017 12:00:00 EDT

Linezolid for Treatment of Nontuberculous Mycobacterial Diseases

Condition:   Non-tuberculous Mycobacterial Infections
Intervention:   Drug: Oral Tablet
Sponsors:   Mahidol University;   Siam Pharmaceutical Ltd.
Recruiting

Tue, 18 Jul 2017 12:00:00 EDT

Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.

Condition:   Coronavirus Disease 2019 (COVID-19)
Interventions:   Biological: COVID-19 convalescent plasma;   Biological: Anti-COVID-19 human immunoglobulin;   Drug: Standard (specific) therapy for COVID-19
Sponsor:   Lifefactors Zona Franca, SAS
Not yet recruiting

Wed, 20 May 2020 12:00:00 EDT

Adverse Events Related to Treatments Used Against Coronavirus Disease 2019

Conditions:   Coronavirus;   Iatrogenic Disease;   Acute Kidney Injury;   ARDS, Human
Intervention:   Drug: Any drug used to treat Covid-19
Sponsors:   Groupe Hospitalier Pitie-Salpetriere;   CMC Ambroise Paré
Recruiting

Thu, 19 Mar 2020 12:00:00 EDT

Identification of TT Cases by Community Treatment Assistants: An Assessment

Condition:   Trichiasis
Intervention:   Other: TT Training Program and TT Screening Card
Sponsors:   Johns Hopkins University;   Lions Club International Foundation
Completed

Tue, 05 Feb 2013 12:00:00 EST

The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol

Condition:   CoVid 19 Positive
Interventions:   Drug: Hydroxychloroquine, Azithromycin;   Drug: Hydroxychloroquine, Doxycycline;   Drug: Hydroxychloroquine, Clindamycin;   Drug: Hydroxychloroquine, Clindamycin, Primaquine - low dose.;   Drug: Hydroxychloroquine, Clindamycin, Primaquine - high dose.;   Drug: Remdesivir;   Drug: Tocilizumab;   Drug: Methylprednisolone;   Drug: Interferon-Alpha2B;   Drug: Losartan;   Drug: Convalescent Serum
Sponsor:   The Camelot Foundation
Completed

Thu, 16 Apr 2020 12:00:00 EDT

Expedited Partner Therapy for MSM in Peru

Conditions:   Gonorrhea;   Chlamydia
Intervention:   Behavioral: EPT
Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH);   Asociación Civil Impacta Salud y Educación, Peru
Completed

Fri, 02 Nov 2012 12:00:00 EDT

Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar

Conditions:   Sexually Transmitted Infections;   Schistosoma Haematobium
Intervention:   Drug: Treatment with anti-STI and anti-schistosoma regimens
Sponsors:   University of Aarhus;   Statens Serum Institut
Completed

Mon, 14 Jul 2008 12:00:00 EDT

Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)

Conditions:   Drug Resistance, Microbial;   Antimicrobial Stewardship;   Gonorrhea
Intervention:   Other: Resistance guided treatment for gonorrhoea infection
Sponsors:   The University of Queensland;   Kirby Institute;   Monash University;   South Australian Health and Medical Research Institute;   University of Melbourne;   University of California, Los Angeles;   Griffith University;   Queensland Health;   SydPath - St Vincent's Pathology;   SpeeDx Pty. Ltd.;   NSW Health Pathology;   University of Sydney
Not yet recruiting

Thu, 13 Feb 2020 12:00:00 EST

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal

Condition:   COVID-19
Intervention:   Drug: Nafamostat Mesilate
Sponsors:   Institut Pasteur de Dakar;   Fann Hospital, Senegal;   Ministry of Health, Senegal;   Diamniadio Children Hospital, Senegal;   Dalal Jamm Hospital, Senegal;   Institut Pasteur Korea
Recruiting

Fri, 15 May 2020 12:00:00 EDT

Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia

Condition:   Community Acquired Pneumonia
Interventions:   Drug: Andrographolid Sulfonate Injection (AS Injection);   Drug: Cephalosporin;   Drug: Azithromycin, Minocycline or Doxycycline;   Drug: Amoxicillin-clavulantic acid;   Drug: Fluoroquinolones;   Drug: Placebo
Sponsor:   Qingfeng Pharmaceutical Group
Unknown status

Fri, 23 Sep 2016 12:00:00 EDT

The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19

Condition:   Covid19
Interventions:   Drug: Favipiravir;   Drug: Oseltamivir 75mg
Sponsor:   Indonesia University
Recruiting

Tue, 22 Sep 2020 12:00:00 EDT

Patients Response to Early Switch To Oral:Osteomyelitis Study

Condition:   Osteomyelitis
Interventions:   Drug: oral antibiotics;   Procedure: intravenous antibiotics
Sponsors:   Julio Ramirez;   University of Louisville
Terminated

Fri, 28 Mar 2014 12:00:00 EDT

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Condition:   Tuberculosis, Multidrug-Resistant
Interventions:   Drug: Individualized TB treatment with multiple drugs;   Drug: Standardized TB treatment with multiple drugs
Sponsor:   Centre for the AIDS Programme of Research in South Africa
Recruiting

Wed, 02 Aug 2017 12:00:00 EDT

Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis

Condition:   Cat-Scratch Disease
Interventions:   Drug: gentamicin;   Drug: placebo
Sponsor:   University Hospital, Toulouse
Recruiting

Thu, 27 Apr 2017 12:00:00 EDT

Phase 2a Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Condition:   Mycobacterium Avium Complex
Interventions:   Drug: SPR720;   Drug: Placebo;   Drug: Open-label SOC
Sponsor:   Spero Therapeutics
Terminated

Thu, 17 Sep 2020 12:00:00 EDT

Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial

Condition:   Coronavirus
Interventions:   Biological: Plasma exchange;   Drug: Standar medical treatmen
Sponsor:   Fundacion Clinic per a la Recerca Biomédica
Recruiting

Tue, 05 May 2020 12:00:00 EDT

Tannin Specific Natural Extract for COVID-19 Infection

Conditions:   COVID-19;   SARS-CoV 2;   Coronavirus Infection
Interventions:   Dietary Supplement: ARBOX;   Other: PLACEBO
Sponsors:   Hospital de Clinicas José de San Martín;   SILVATEAM
Terminated

Wed, 27 May 2020 12:00:00 EDT

Multicenter Analysis of Efficacy and Outcomes of Extracorporeal Photopheresis as Treatment of Chronic Lung Allograft Dysfunction

Condition:   Lung Transplant Rejection
Intervention:   Device: Extracorporeal photopheresis
Sponsor:   Medical University of Vienna
Active, not recruiting

Wed, 10 Mar 2021 12:00:00 EST

Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure

Condition:   Pertussis
Intervention:   Drug: Antibiotic PEP
Sponsors:   Vanderbilt University;   Centers for Disease Control and Prevention
Completed

Fri, 04 May 2007 12:00:00 EDT

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

Conditions:   Pneumonia, Viral;   Cytokine Storm
Interventions:   Radiation: Ultra-Low-dose radiotherapy;   Device: ventilatory support with oxygen therapy;   Drug: Lopinavir/ritonavir;   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Drug: Piperacillin/tazobactam;   Drug: Low molecular weight heparin;   Drug: Corticosteroid injection;   Drug: Tocilizumab
Sponsors:   Fundacion GenesisCare;   Hospital La Milagrosa;   Hospital Vithas Valencia Consuelo
Recruiting

Tue, 19 May 2020 12:00:00 EDT

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Condition:   Pneumonia, Viral
Interventions:   Radiation: Low-dose radiotherapy;   Drug: Hydroxychloroquine Sulfate;   Drug: Ritonavir/lopinavir;   Drug: Tocilizumab Injection [Actemra];   Drug: Azithromycin;   Drug: Corticosteroid;   Drug: Low molecular weight heparin;   Device: Oxygen supply
Sponsors:   Grupo de Investigación Clínica en Oncología Radioterapia;   Hospital Universitario Madrid Sanchinarro;   Hospital del Mar;   Hospital Universitari Sant Joan de Reus
Recruiting

Fri, 08 May 2020 12:00:00 EDT

Covid-19 and Diabetes in West of Algeria

Conditions:   Coronavirus Infections;   Diabetes Mellitus;   Prevalence;   Risk Factors;   Patient Outcome Assessment;   Severe Acute Respiratory Syndrome
Intervention:   Drug: MANAGEMENT OF COVID-19
Sponsors:   Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen;   ATRSS, DGRST, Algeria
Recruiting

Tue, 02 Jun 2020 12:00:00 EDT

Comparative Effectiveness of Antibiotics for Respiratory Infections

Conditions:   Acute Otitis Media;   Acute Sinusitis;   Group A Streptococcal Pharyngitis
Interventions:   Drug: Broad-spectrum antibiotics;   Drug: Narrow-spectrum antibiotics
Sponsor:   Children's Hospital of Philadelphia
Completed

Fri, 21 Nov 2014 12:00:00 EST

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

Conditions:   Cystic Fibrosis;   Chronic Bronchitis
Interventions:   Drug: IV amikacin;   Drug: PO azithromycin;   Drug: IV ceftazidime;   Drug: PO ciprofloxacin;   Drug: IV meropenem;   Drug: IV piperacillin-tazobactam;   Drug: IV ticarcillin-clavulanate;   Drug: IV tobramycin
Sponsors:   Seattle Children's Hospital;   Cystic Fibrosis Foundation
Completed

Mon, 12 Sep 2005 12:00:00 EDT

Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic

Condition:   Covid19
Interventions:   Drug: Ivermectin;   Drug: Hydroxychloroquine;   Behavioral: personal protective Measures
Sponsor:   Benha University
Completed

Wed, 16 Dec 2020 12:00:00 EST

Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.

Condition:   Helicobacter Pylori Gastritis
Interventions:   Drug: CLA (Clarithro+Lanso+Amoxi);   Drug: PLA (Panto+Levoflox+Azithro)
Sponsors:   Asofarma de México S.A de C.V.;   Hospital Ángeles, Clínica Londres, Mexico City;   Centro InmunoQ, Mexico City;   Torre Mayo, Metepec, State of Mexico;   Hospital Ángeles Metropolitano, Mexico City;   Centro Médico ABC Observatorio, Mexico City
Completed

Fri, 01 Apr 2016 12:00:00 EDT

Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)

Condition:   SARS-CoV-2
Interventions:   Drug: Alisporivir;   Other: Standard of care (SOC)
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Debiopharm International SA
Not yet recruiting

Thu, 29 Oct 2020 12:00:00 EDT

The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection

Condition:   COVID-19
Intervention:   Drug: Colchicine Tablets
Sponsor:   Shahid Beheshti University of Medical Sciences
Recruiting

Fri, 24 Apr 2020 12:00:00 EDT

Ivermectin Versus Standard Treatment in Mild COVID-19

Condition:   Covid19
Intervention:   Drug: Ivermectin Tablets
Sponsor:   Assiut University
Not yet recruiting

Thu, 24 Jun 2021 12:00:00 EDT

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Condition:   SARS-CoV-2 Infection
Interventions:   Drug: Drug COVID19-0001-USR;   Drug: normal saline
Sponsor:   United Medical Specialties
Recruiting

Tue, 20 Oct 2020 12:00:00 EDT

Macrolide in Pregnancy and Adverse Child Outcomes

Condition:   Infection
Interventions:   Drug: Macrolides;   Drug: Penicillins
Sponsor:   Institute of Child Health
Completed

Tue, 14 May 2019 12:00:00 EDT

MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

Conditions:   Lung Diseases, Interstitial;   Hematopoietic Stem Cell Transplantation;   Bronchiolitis Obliterans
Interventions:   Biological: MSCs;   Drug: AZM;   Drug: Glucocorticoid
Sponsors:   Nanfang Hospital of Southern Medical University;   Sun Yat-sen University
Unknown status

Mon, 07 Sep 2015 12:00:00 EDT

Isotretinoin in Treatment of COVID-19

Condition:   COVID-19
Intervention:   Drug: Isotretinoin Only Product in Oral Dose Form
Sponsor:   Tanta University
Not yet recruiting

Fri, 24 Apr 2020 12:00:00 EDT

Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections

Conditions:   Pneumonia;   Acute Exacerbation of Chronic Obstructive Airways Disease
Interventions:   Other: PCT-level;   Behavioral: Antibiotic treatment based on PCT-level
Sponsors:   Holbaek Sygehus;   Region Sjælland;   Aase and Ejnar Danielsens Foundation
Unknown status

Tue, 24 Jun 2014 12:00:00 EDT

Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion

Conditions:   Bronchopulmonary Dysplasia;   Necrotizing Enterocolitis;   Intracranial Hemorrhages
Intervention:   Combination Product: Continuous amnioinfusion with Amnion Flush Solution through the intraamniotic catheter
Sponsor:   Martin-Luther-Universität Halle-Wittenberg
Not yet recruiting

Wed, 06 Jan 2021 12:00:00 EST

Population Pharmacokinetics of Anti-infective Drugs in Children With Infectious Diseases

Condition:   Children; Infection
Intervention:   Drug: cephalosporins,penicillins,macrolides,carbapenems and antiviral drugs
Sponsors:   Beijing Children's Hospital;   Shandong University;   Robert Debré Hospital;   Rennes University Hospital
Recruiting

Thu, 13 Apr 2017 12:00:00 EDT

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Conditions:   Coronavirus Infection (COVID-19);   Pulmonary Arterial Hypertension;   Urinary Tract Infections in Children;   Hypertension;   Pain;   Hyperphosphatemia;   Primary Hyperaldosteronism;   Edema;   Hypokalemia;   Heart Failure;   Hemophilia;   Menorrhagia;   Insomnia;   Pneumonia;   Skin Infection;   Arrythmia;   Asthma in Children;   Bronchopulmonary Dysplasia;   Adrenal Insufficiency;   Fibrinolysis; Hemorrhage;   Attention Deficit Hyperactivity Disorder;   Multisystem Inflammatory Syndrome in Children (MIS-C);   Kawasaki Disease;   Coagulation Disorder;   Down Syndrome
Intervention:   Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:
Sponsors:   Duke University;   The Emmes Company, LLC;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Thu, 20 Feb 2020 12:00:00 EST

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.

Condition:   Covid19
Interventions:   Drug: Selenium (as Selenious Acid);   Other: Placebo
Sponsors:   CHRISTUS Health;   Pharco Pharmaceuticals
Not yet recruiting

Mon, 03 May 2021 12:00:00 EDT

Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT

Conditions:   Assisted Reproductive Technology;   Antibiotic Prophylaxis;   Embryo Transfer
Intervention:   Other: Withholding antibiotic prophylaxis
Sponsor:   Washington University School of Medicine
Terminated

Fri, 29 Dec 2017 12:00:00 EST

An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19

Conditions:   Acute Respiratory Tract Infection;   Acute Respiratory Insufficiency;   Pneumonia;   Septic Shock;   Hypoxemia
Interventions:   Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation.;   Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection;   Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin inhalation;   Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection combined with Dalargin inhalation
Sponsor:   Burnasyan Federal Medical Biophysical Center
Completed

Wed, 15 Apr 2020 12:00:00 EDT

Effects of Periodontal Therapy in Patients With Metabolic Syndrome

Conditions:   Periodontitis;   Metabolic Syndrome
Interventions:   Procedure: Scaling and root planning;   Procedure: Supragingival Prophylaxis
Sponsors:   Universidad Complutense de Madrid;   Colgate Palmolive
Completed

Thu, 23 May 2019 12:00:00 EDT

Washington State Community Expedited Partner Treatment (EPT) Trial

Conditions:   Gonorrhea;   Neisseria Gonorrhoeae;   Chlamydia Trachomatis
Interventions:   Other: Patient delivered partner therapy;   Behavioral: Targeted public health partner services
Sponsors:   University of Washington;   Washington State, Department of Health;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 15 Aug 2012 12:00:00 EDT

Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

Conditions:   Delirium;   QT-prolongation
Intervention:   Drug: Haloperidol, azi/clari/erythromycin, levo/moxifloxacin, co-trimoxazole, vori/keto/flu/itraconazole, methadone, tacrolimus, sunitinib
Sponsors:   KU Leuven;   Agentschap voor Innovatie door Wetenschap en Technologie
Completed

Fri, 21 Feb 2014 12:00:00 EST

Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients

Condition:   Covid19
Interventions:   Drug: Ivermectin and Doxycyline;   Drug: Standard of care
Sponsor:   Alkarkh Health Directorate-Baghdad
Completed

Mon, 19 Oct 2020 12:00:00 EDT

Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial

Condition:   Coronavirus Infection
Interventions:   Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed;   Drug: Group 2: control group with enoxaparin 40mg/d
Sponsors:   Brazilian Clinical Research Institute;   Hospital Israelita Albert Einstein;   Hospital do Coracao;   Hospital Sirio-Libanes;   Hospital Moinhos de Vento;   Hospital Alemão Oswaldo Cruz;   Beneficência Portuguesa de São Paulo;   Brazilian Research In Intensive Care Network
Completed

Tue, 19 May 2020 12:00:00 EDT

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Condition:   COVID-19 Acute Respiratory Distress Syndrome
Intervention:   Drug: Potassium Canrenoate
Sponsors:   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   University of Milan;   IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not yet recruiting

Tue, 27 Jul 2021 12:00:00 EDT

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Condition:   COVID-19
Interventions:   Drug: Favipiravir;   Drug: Standard of care
Sponsor:   Promomed, LLC
Completed

Wed, 09 Sep 2020 12:00:00 EDT

Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial

Condition:   SARS Pneumonia
Interventions:   Biological: Convalescent Plasma of patients with COVID-19;   Other: placebo (hartmann plus albumine)
Sponsors:   Grupo Mexicano para el Estudio de la Medicina Intensiva;   Hospital General Naval de Alta Especialidad - Escuela Medico Naval;   National Institute of Pediatrics, Mexico;   Instituto Nacional de Enfermedades Respiratorias
Completed

Thu, 28 May 2020 12:00:00 EDT

Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.

Conditions:   Helicobacter Pylori Infection;   Antimicrobial Susceptibility Testing
Interventions:   Drug: two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone and tetracycline);   Drug: two antibiotics based on personal medication history(amoxicillin,clarithromycin,furazolidone);   Drug: one proton pump inhibitor(PPI);   Drug: Colloidal Bismuth Pectin;   Drug: two antibiotics for failed eradication(tetracyclin,furazolidone)
Sponsor:   Shandong University
Unknown status

Wed, 27 Jun 2018 12:00:00 EDT

Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China

Conditions:   HIV Infections;   Gonorrhea;   Chlamydia
Interventions:   Behavioral: Physician Ai Shi Zi training;   Drug: Standard care;   Behavioral: Patient risk-reduction counseling
Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH)
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics

Condition:   Age-related Macular Degeneration
Intervention:   Procedure: Conjunctival and nasopharyngeal bacteria cultures
Sponsor:   Vanderbilt University
Completed

Thu, 29 Jan 2009 12:00:00 EST

A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events

Conditions:   Retinal Detachment;   Achilles Tendon;   Aneurysm, Dissecting
Interventions:   Drug: Oral Fluoroquinolones (FQ);   Drug: Other Antibiotics;   Other: Febrile Illness Not Treated with Antibiotics Will be Analyzed as an Exposure
Sponsor:   Janssen Research & Development, LLC
Completed

Tue, 27 Mar 2018 12:00:00 EDT

C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.

Condition:   COVID -19
Interventions:   Drug: Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins;   Drug: Oral low dose steroid;   Drug: Intravenous Antibiotics with Low dose steroid.;   Drug: Oral anti-coagulant
Sponsors:   Manimarane Arjunan, MD,DM (Cardiology);   UR Anoop Research Group
Completed

Wed, 23 Jun 2021 12:00:00 EDT

Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)

Condition:   COVID19
Interventions:   Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment;   Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment;   Drug: Isotretinoin (13 cis retinoic acid ) capsules;   Drug: Aerosolized 13 cis retinoic acid;   Drug: Standard treatment
Sponsors:   Kafrelsheikh University;   1-Foshan University Laboratory of Emerging Infectious Disease Institute of Translational Medicine The First Hospital of Jilin University China;   2-Montefiore Health System and Albert Einstein College of Medicine, Newyork, United States of America (U.S.A).;   2-Faculty of Science, Kafrelsheikh University, Egypt.
Not yet recruiting

Mon, 20 Apr 2020 12:00:00 EDT

Cholera Anti-Secretory Treatment Trial

Condition:   Cholera
Interventions:   Drug: iOWH032;   Drug: Placebo;   Other: V. cholerae Challenge;   Drug: Antibiotics
Sponsors:   PATH;   University of Maryland, Baltimore;   Pharmaron
Completed

Mon, 04 Nov 2019 12:00:00 EST

Asthma Research in Children and Adolescents

Conditions:   Persistent Asthma;   Asthma in Children;   Asthma Exacerbation
Interventions:   Drug: Inhaled Corticosteroids (ICs);   Drug: Fixed-Dose Combination of Inhaled Corticosteroids and Long- Acting Beta-agonist (ICs/LABA);   Drug: Other treatments;   Drug: Inhaler device;   Behavioral: Regularly monitoring of the Inhalation technique through mobile app
Sponsor:   Parc de Salut Mar
Recruiting

Tue, 21 Jul 2020 12:00:00 EDT

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Condition:   Community-acquired Pneumonia, Influenza, COVID-19
Interventions:   Drug: Fixed-duration Hydrocortisone;   Drug: Shock-dependent hydrocortisone;   Drug: Ceftriaxone;   Drug: Moxifloxacin or Levofloxacin;   Drug: Piperacillin-tazobactam;   Drug: Ceftaroline;   Drug: Amoxicillin-clavulanate;   Drug: Macrolide administered for 3-5 days;   Drug: Macrolide administered for up to 14 days;   Drug: Five-days oseltamivir;   Drug: Ten-days oseltamivir;   Drug: Lopinavir/ritonavir;   Drug: Hydroxychloroquine;   Drug: Hydroxychloroquine + lopinavir/ritonavir;   Drug: Interferon-β1a;   Drug: Anakinra;   Drug: Fixed-duration higher dose Hydrocortisone;   Drug: Tocilizumab;   Drug: Sarilumab;   Drug: Vitamin C;   Drug: Therapeutic anticoagulation;   Drug: Simvastatin;   Biological: Convalescent plasma;   Other: Protocolised mechanical ventilation strategy;   Drug: Eritoran;   Drug: Apremilast;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Ticagrelor
Sponsors:   MJM Bonten;   Australian and New Zealand Intensive Care Research Centre;   Medical Research Institute of New Zealand;   Unity Health;   Berry Consultants;   Global Coalition for Adaptive Research;   University of Pittsburgh Medical Center
Recruiting

Wed, 13 Apr 2016 12:00:00 EDT

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

Conditions:   Malaria;   Plasmodium Falciparum Malaria
Interventions:   Biological: PfSPZ Challenge;   Biological: 0.9% Sodium Chloride (Placebo)
Sponsors:   Sanaria Inc.;   Institute of Tropical Medicine, University of Tuebingen;   German Federal Ministry of Education and Research
Completed

Wed, 16 Apr 2014 12:00:00 EDT